Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
23 "Atherosclerosis"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Articles
Diabetes, obesity and metabolism
Coronary Artery Calcium Score as a Sensitive Indicator of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus: A Long-Term Cohort Study
Dae-Jeong Koo, Mi Yeon Lee, Sun Joon Moon, Hyemi Kwon, Sang Min Lee, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki Won Oh, Sung Rae Cho, Young-Hoon Jeong, Eun-Jung Rhee
Endocrinol Metab. 2023;38(5):568-577.   Published online October 10, 2023
DOI: https://doi.org/10.3803/EnM.2023.1770
  • 10,290 View
  • 225 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Coronary artery calcium score (CACS) has become an important tool for evaluating cardiovascular disease (CVD). This study evaluated the significance of CACS for future CVD through more than 10 years of follow-up in asymptomatic Korean populations with type 2 diabetes mellitus (T2DM) known to have a relatively low CACS burden.
Methods
We enrolled 981 asymptomatic T2DM patients without CVD at baseline who underwent CACS evaluation using multidetector computed tomography between January 2008 and December 2014. They were grouped into five predefined CACS categories based on Agatston scores and followed up by August 2020. The primary endpoint was incident CVD events, including coronary, cerebrovascular, and peripheral arterial disease.
Results
The relative risk of CVD was significantly higher in patients with CACS ≥10, and the significance persisted after adjustment for known confounders. A higher CACS category indicated a higher incidence of future CVD: hazard ratio (95% confidence interval) 4.09 (1.79 to 9.36), 12.00 (5.61 to 25.69), and 38.79 (16.43 to 91.59) for 10≤ CACS <100, 100≤ CACS <400, and CACS ≥400, respectively. During the 12-year follow-up period, the difference in event-free survival more than doubled as the category increased. Patients with CACS below 10 had very low CVD incidence throughout the follow-up. The receiver operating characteristic analysis showed better area under curve when the CACS cutoff was 10 than 100.
Conclusion
CACS can be a sensitive marker of CVD risk. Specifically, CACS above 10 is an indicator of CVD high-risk requiring more intensive medical treatment in Koreans with T2DM.

Citations

Citations to this article as recorded by  
  • Innovative Lipid-Lowering Strategies: RNA-Based, Small Molecule, and Protein-Based Therapies
    Youngwoo Jang, Eun-Jung Rhee, Sung Hee Choi
    Endocrinology and Metabolism.2025; 40(5): 668.     CrossRef
Close layer
Diabetes, obesity and metabolism
Triglyceride-Glucose Index Predicts Future Atherosclerotic Cardiovascular Diseases: A 16-Year Follow-up in a Prospective, Community-Dwelling Cohort Study
Joon Ho Moon, Yongkang Kim, Tae Jung Oh, Jae Hoon Moon, Soo Heon Kwak, Kyong Soo Park, Hak Chul Jang, Sung Hee Choi, Nam H. Cho
Endocrinol Metab. 2023;38(4):406-417.   Published online August 3, 2023
DOI: https://doi.org/10.3803/EnM.2023.1703
  • 24,659 View
  • 368 Download
  • 42 Web of Science
  • 43 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
While the triglyceride-glucose (TyG) index is a measure of insulin resistance, its association with cardiovascular disease (CVD) has not been well elucidated. We evaluated the TyG index for prediction of CVDs in a prospective large communitybased cohort.
Methods
Individuals 40 to 70 years old were prospectively followed for a median 15.6 years. The TyG index was calculated as the Ln [fasting triglycerides (mg/dL)×fasting glucose (mg/dL)/2]. CVDs included any acute myocardial infarction, coronary artery disease or cerebrovascular disease. We used a Cox proportional hazards model to estimate CVD risks according to quartiles of the TyG index and plotted the receiver operating characteristics curve for the incident CVD.
Results
Among 8,511 subjects (age 51.9±8.8 years; 47.5% males), 931 (10.9%) had incident CVDs during the follow-up. After adjustment for age, sex, body mass index, diabetes mellitus, hypertension, total cholesterol, smoking, alcohol, exercise, and C-reactive protein, subjects in the highest TyG quartile had 36% increased risk of incident CVD compared with the lowest TyG quartile (hazard ratio, 1.36; 95% confidence interval, 1.10 to 1.68). Carotid plaque, assessed by ultrasonography was more frequent in subjects in the higher quartile of TyG index (P for trend=0.049 in men and P for trend <0.001 in women). The TyG index had a higher predictive power for CVDs than the homeostasis model assessment of insulin resistance (HOMA-IR) (area under the curve, 0.578 for TyG and 0.543 for HOMA-IR). Adding TyG index on diabetes or hypertension alone gave sounder predictability for CVDs.
Conclusion
The TyG index is independently associated with future CVDs in 16 years of follow-up in large, prospective Korean cohort.

Citations

Citations to this article as recorded by  
  • Triglyceride glucose index and modified triglyceride glucose indices are instrumental to optimize 3P medical management for postpartum cardiovascular disease
    Dong Lin, Haoxian Tang, Enoch Odame Anto, Yueran Zhou, Shenglan Zhang, Xiulian Deng, Cuihong Tian, Weijie Cao, Zhuoqiao He, Zhisheng Chen, Pengxiang Ying, Yequn Chen, Xuerui Tan
    EPMA Journal.2026; 17(1): 105.     CrossRef
  • Association between cumulative changes of the triglyceride glucose index and incidence of Cardio-cerebral vascular diseases in a population with cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study
    Li Hou, Jing Tang, Lei Zhang, Yanhong Li, Yao Niu
    Journal of Stroke and Cerebrovascular Diseases.2026; 35(2): 108540.     CrossRef
  • Risk Determinants of Type 2 Diabetes Mellitus with Severe Obesity and Prediction Model for Diabetes Remission after Bariatric Metabolic Surgery
    Zilong Wu, Yuxia Li, Dehui Wang, Bing Wu, Kaisheng Yuan, Yun Liu, Hao Zhu, Sijie Chen, Wah Yang, Ruixiang Hu, Cunchuan Wang
    Diabetes & Metabolism Journal.2026; 50(2): 368.     CrossRef
  • Elevated triglyceride‐glucose index is associated with increased risk of chronic kidney disease and end‐stage renal disease in type 1 diabetes: Nationwide cohort study
    Rosa Oh, Seohyun Kim, So Hyun Cho, Ji Yoon Kim, Myunghwa Jang, Sang Ho Park, You‐Bin Lee, Sang‐Man Jin, Kyu Yeon Hur, Gyuri Kim, Jae Hyeon Kim
    Diabetes, Obesity and Metabolism.2026; 28(4): 2784.     CrossRef
  • Triglyceride-Glucose Index and Mortality Risk in the General Population: A Systematic Review and Meta-analysis of Prospective Studies
    D’Elia Lanfranco, Saverio Stranges, Ersilia La Fata, Francesca Fortunato, Raffaele Palladino, Domenico Rendina, Ferruccio Galletti
    High Blood Pressure & Cardiovascular Prevention.2026; 33(4): 381.     CrossRef
  • Interpretable machine learning analysis of routine blood biomarkers and derived indicators for predicting coronary heart disease in patients with carotid stenosis
    Wenzhuang Li, Kaiming Gao, Haihong Zhang, Weidong Xia, Bilali Balajiang, Hongguang Wang, Xiaoguang Tong
    BMC Cardiovascular Disorders.2026;[Epub]     CrossRef
  • Association of cardiometabolic risk factors with remnant cholesterol in female law enforcement officers
    Kris Gratia Ageng Nanda, Meity Ardiana, Ovin Nada Saputri, Raditya Rizki Muhammad, Nadya Noor Mulya Putri, Mohammed Hamzah Raka Pratama
    Multidisciplinary Science Journal.2026; 8(9): 2026517.     CrossRef
  • Dynamic Changes in Triglyceride Glucose‒Waist‒to‒Height Ratio and the Risk of Major Adverse Cardiovascular Events: Role of Concurrent Mean Arterial Pressure Change
    Xingyu Luo, Qixian Zhang, Fangfang Fan, Yanyan Zhang, Weijie Hou, Yu Zhan, Bo Zheng, Yanjun Gong, Yan Zhang
    The Journal of Clinical Hypertension.2026;[Epub]     CrossRef
  • Asociación del índice de triglicéridos-glucosa (índice TyG) y el riesgo cardiovascular en adultos de la ciudad de Tulcán, 2025
    Mario Alexander Aguilar Balseca, Deyaneira Dayana Cevallos Arteaga, Paola Nayeli Hurtado Guerra, Carlos Alejandro Sánchez Guamán, Fernando Javier Puetate Malte
    Esprint Investigación.2026; 5(1): 774.     CrossRef
  • Comparative discriminatory performance of emerging endocrine-metabolic indices versus obesity indices for cardiometabolic multimorbidity in older adults: a cross-sectional study
    Haosen Pan, Qianqian Zhang, Yuanyuan Wang, Ankai Chen, Xintao Chen, Liping Ren, Maoyun Miao
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • TyG Index and Frailty as Composite Biomarkers of Cardiometabolic Risk and Mortality Across CKM Stages 0–3
    Yaocheng Luo, Peng Zeng, Shuoya Huang, Zhenzhen Peng, Jian Zheng, Zumin Shi, Manoj Sharma, Yong Zhao
    Metabolites.2026; 16(6): 426.     CrossRef
  • Elevated triglyceride-glucose index as a predictor of carotid plaque incidence: Insights from a comprehensive meta-analysis
    Arankesh Mahadevan, Bhavin A. Patel, Sashwath Srikanth, Raja Godasi, Rupak Desai
    The American Journal of the Medical Sciences.2025; 369(2): 197.     CrossRef
  • Analysis of the correlation between the serum triglyceride glucose index and the risk of death in patients on maintenance hemodialysis: a retrospective cohort study
    Xiaokeng Chi, Shuxin Chen, Zhe Huang, Rong Zhou, Zhicheng Su, Qiujun Mai, Yilin Xu, Jianxin Wan
    PeerJ.2025; 13: e18781.     CrossRef
  • Assessing the predictive value of elevated triglycerides, triglyceride-glucose index (TyG), and TG/HDL ratios for cardiovascular disease and mortality during 20 years of follow-up: Tehran lipid and glucose study
    Shayesteh Khalili, Atieh Amouzegar, Seyed Sattar Dorost, Fereidoun Azizi, Aryan Salahi-Niri
    Clinical Biochemistry.2025; 136: 110891.     CrossRef
  • Association between triglyceride-glucose index and carotid atherosclerosis in Chinese steelworkers: a cross-sectional study
    Haoyue Cao, Qinglin Li, Juxiang Yuan
    Scientific Reports.2025;[Epub]     CrossRef
  • Association between the triglyceride-glucose index and silent myocardial infarction in the general population
    Min Dai, Dongze Li, Jing Yu, Yi Liu, Qin Zhang, Wei Zhang, Yan Zhong, Zhi Wan, Menglin Tang, Yongli Gao, Li Rao
    Scientific Reports.2025;[Epub]     CrossRef
  • Integrative Multi‐Omics and Routine Blood Analysis Using Deep Learning: Cost‐Effective Early Prediction of Chronic Disease Risks
    Zhibin Dong, Pei Li, Yi Jiang, Zhihan Wang, Shihui Fu, Hebin Che, Meng Liu, Xiaojing Zhao, Chunlei Liu, Chenghui Zhao, Qin Zhong, Chongyou Rao, Siwei Wang, Suyuan Liu, Dayu Hu, Dongjin Wang, Juntao Gao, Kai Guo, Xinwang Liu, En Zhu, Kunlun He
    Advanced Science.2025;[Epub]     CrossRef
  • Impact of steatotic liver disease categories on atrial fibrillation in type 2 diabetes: a nationwide study
    So Hyun Cho, Gyuri Kim, Kyu-na Lee, Rosa Oh, Ji Yoon Kim, Myunghwa Jang, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Kyungdo Han, Jae Hyeon Kim
    Scientific Reports.2025;[Epub]     CrossRef
  • The Triglyceride-Glucose Index and Risk of End-Stage Renal Disease across Different Durations of Type 2 Diabetes Mellitus: A Longitudinal Cohort Study
    Mi-sook Kim, Kyu-Na Lee, Jeongmin Lee, Jeongeun Kwak, Seung-Hwan Lee, Hyuk-Sang Kwon, Jing Hughes, Kyung-Do Han, Eun Young Lee
    Endocrinology and Metabolism.2025; 40(5): 718.     CrossRef
  • Associations Between Novel Lipid Indicators and the Risk of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
    Yazhi Wang, Mingkang Zhang, Peng Wang
    Lipids.2025; 60(6): 407.     CrossRef
  • The triglyceride-glucose index, a marker of insulin resistance, as a predictor of thrombotic risk in atrial fibrillation
    José Miguel Rivera-Caravaca, Eva Soler-Espejo, María Pilar Ramos-Bratos, Raquel López-Gálvez, Eduardo González-Lozano, Gregory Y. H. Lip, Francisco Marín, Vanessa Roldán
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • The Impact of Triglyceride-Glucose Index Trajectories on Incidence and Recurrent Cardiovascular Events: Evidence from a Retrospective Cohort Study
    Yuan Xu, Gonglong Wu, Long Jiang, Xinlei Yang, Chengjin Wen, Yulan Yang, Hui Hu
    Vascular Health and Risk Management.2025; Volume 21: 557.     CrossRef
  • Association between the Triglyceride-Glucose Index and Cardiovascular Risk and Mortality across Different Diabetes Durations: A Nationwide Cohort Study
    Jeongeun Kwak, Kyung-Do Han, Eun Young Lee, Seung-Hwan Lee, Dong-Jun Lim, Hyuk-Sang Kwon, Jeongmin Lee
    Endocrinology and Metabolism.2025; 40(4): 548.     CrossRef
  • Does diabetes status modify the association between the triglyceride-glucose index and major adverse cardiovascular events in patients with coronary heart disease? A systematic review and meta-analysis of longitudinal cohort studies
    Shicong Xu, Zhihui Zhang, Jing Li, Yiyan Ding, Yuanguo Chen, Yunxia Zhou, Shenglin Hu
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • Predictive performance of traditional and novel anthropometric indices for diabetes and hypertension
    Mozhgan Pezeshki, Shirin Esmaeili, Armita Mahdavi‐Gorabi, Tahereh Sadegi, Zahra Farhad Kiaee, Omid Assar, Kiavash Semnani, Mostafa Qorbani
    Journal of Diabetes Investigation.2025; 16(12): 2213.     CrossRef
  • Asociación del Índice de triglicéridos-glucosa (Índice TyG) y el riesgo cardiovascular en docentes de educación superior.
    Luiggi Oscar Solano-Maza, Jhon Bryan Mina-Ortiz, Anita María Murillo-Zavala, Karina Maricela Merchán-Villafuerte
    Innova Science Journal.2025; 3(4): 397.     CrossRef
  • Association of the triglyceride-glucose index with cardiovascular outcomes across cardiovascular-kidney-metabolic syndrome stages
    Byung Sik Kim, Hyun-Jin Kim, Shinje Moon, Hasung Kim, Jungkuk Lee, Jeong-Hun Shin
    The Korean Journal of Internal Medicine.2025; 40(6): 961.     CrossRef
  • Association between the triglyceride-glucose index and carotid plaque progression in patients with type 2 diabetes mellitus: a retrospective cohort study
    Zhangxiang Zhu, Xuan Xu, Guojuan Wang, Qianqian Zhang, Ying Li, Jun Zhu, Li Chen, Qibao Ye, Mingwei Chen
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Associations Between Serum Selenium, Zinc, and Copper Levels and Cognitive Function in the Elderly
    Piangporn Charernwat, Sirintorn Chansirikarnjana, Pachara Panpunuan, Piyamitr Sritara, Jintana Sirivarasai
    Nutrients.2025; 17(24): 3872.     CrossRef
  • Machine learning based model for predicting cardiovascular disease using dynamic triglyceride-glucose index: a longitudinal study cohort CHARLS database
    Yi YANG, Zen-Gao YANG, Hong-Hong ZHANG, Zheng-Feng WU, Hai-Jing ZHAO, Yue ZHU, Yu-Han MA, Yu-Qi LIU
    Journal of Geriatric Cardiology.2025; 22(11): 930.     CrossRef
  • Combined with the insulin resistance index in assessing subclinical systolic function in newly diagnosed type 2 diabetes mellitus: an analysis based on automated functional imaging echocardiography
    Shengnan Li, Chaoxue Zhang, Yan Cao, Zhongshun Hu, Danfeng Ni, Zihui Du, Run Chen
    BMC Endocrine Disorders.2025;[Epub]     CrossRef
  • Association between triglyceride-glucose derived indices with cardiometabolic multimorbidity: Findings from the Atherosclerosis Risk in Communities study
    Yi Liu, Dongze Li, Jing Yu, Yongli Gao, Wei Zhang, Menglin Tang, Alessandro Cannavo
    PLOS One.2025; 20(12): e0339646.     CrossRef
  • Construction and validation of a nomogram for predicting diabetes remission at 3 months after bariatric surgery in patients with obesity combined with type 2 diabetes mellitus
    Kaisheng Yuan, Bing Wu, Ruiqi Zeng, Fuqing Zhou, Ruixiang Hu, Cunchuan Wang
    Diabetes, Obesity and Metabolism.2024; 26(1): 169.     CrossRef
  • Association between the triglyceride glucose index and chronic total coronary occlusion: A cross-sectional study from southwest China
    Kaiyong Xiao, Huili Cao, Bin Yang, Zhe Xv, Lian Xiao, Jianping Wang, Shuiqing Ni, Hui Feng, Zhongwei He, Lei Xv, Juan Li, Dongmei Xv
    Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(4): 850.     CrossRef
  • The association between TyG and all-cause/non-cardiovascular mortality in general patients with type 2 diabetes mellitus is modified by age: results from the cohort study of NHANES 1999–2018
    Younan Yao, Bo Wang, Tian Geng, Jiyan Chen, Wan Chen, Liwen Li
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • Comparison of triglyceride glucose index and modified triglyceride glucose indices in prediction of cardiovascular diseases in middle aged and older Chinese adults
    Cancan Cui, Yitian Qi, Jiayin Song, Xinyun Shang, Tianjiao Han, Ning Han, Siqi Yue, Yining Zha, Zhonghang Xu, Jiannan Li, Lin Liu
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • Triglyceride-glucose index predicts type 2 diabetes mellitus more effectively than oral glucose tolerance test-derived insulin sensitivity and secretion markers
    Min Jin Lee, Ji Hyun Bae, Ah Reum Khang, Dongwon Yi, Mi Sook Yun, Yang Ho Kang
    Diabetes Research and Clinical Practice.2024; 210: 111640.     CrossRef
  • Prognostic value of triglyceride-glucose index for left ventricular remodeling in nondiabetic ST-elevation myocardial infarction patients
    Tolga Han Efe, Engin Algül
    Biomarkers in Medicine.2024; 18(6): 243.     CrossRef
  • Triglyceride-Glucose Index as Predictor for Hypertension, CHD and STROKE Risk among Non-Diabetic Patients: A NHANES Cross-Sectional Study 2001–2020
    Bisher Sawaf, Sarya Swed, Hidar Alibrahim, Haidara Bohsas, Tirth Dave, Mohamad Nour Nasif, Wael Hafez, Fatema Ali Asgar Tashrifwala, Yazan Khair Eldien Jabban, Safwan Al-Rassas, Heba haj Saleh, Abdul Rehman Zia Zaidi, Baraa Alghalyini, Shaymaa Abdelmaboud
    Journal of Epidemiology and Global Health.2024; 14(3): 1152.     CrossRef
  • An Increasing Triglyceride–Glucose Index Is Associated with a Pro-Inflammatory and Pro-Oxidant Phenotype
    Beverley Adams-Huet, Ishwarlal Jialal
    Journal of Clinical Medicine.2024; 13(13): 3941.     CrossRef
  • Inflammatory and Metabolic Predictors of Mortality in Pulmonary Thromboembolism: A Focus on the Triglyceride–Glucose Index and Pan-Immune Inflammation Value
    Murat Bilgin, Emre Akkaya, Recep Dokuyucu
    Journal of Clinical Medicine.2024; 13(19): 6008.     CrossRef
  • The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes
    Verena Gounden, Sridevi Devaraj, Ishwarlal Jialal
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Evaluation of the novel three lipid indices for predicting five- and ten-year incidence of cardiovascular disease: findings from Kerman coronary artery disease risk factors study (KERCADRS)
    Alireza Jafari, Hamid Najafipour, Mitra Shadkam, Sina Aminizadeh
    Lipids in Health and Disease.2023;[Epub]     CrossRef
Close layer
Namgok Lecture 2021
Diabetes, Obesity and Metabolism
The Influence of Obesity and Metabolic Health on Vascular Health
Eun-Jung Rhee
Endocrinol Metab. 2022;37(1):1-8.   Published online February 28, 2022
DOI: https://doi.org/10.3803/EnM.2022.101
  • 22,203 View
  • 496 Download
  • 48 Web of Science
  • 55 Crossref
AbstractAbstract PDFPubReader   ePub   
The prevalence of obesity is rapidly increasing worldwide. Obesity should not be understood only as the accumulation of fat in the body, but instead as a phenomenon that exerts different effects on our health according to the place of fat deposition and its stability. Obesity is the starting point of most metabolic diseases, such as diabetes, hypertension, metabolic syndrome, sleep apnea, and eventually cardiovascular disease. There are different kinds of obesity, ranging from simple obesity to sarcopenic obesity. The main purpose of intervening to address obesity is to decrease the ultimate consequence of obesity—namely, cardiovascular disease. The main mechanism through which obesity, especially abdominal obesity, increases cardiovascular risk is the obesity-induced derangement of metabolic health, leading to the development of metabolic diseases such as diabetes, non-alcoholic fatty liver disease, and metabolic syndrome, which are the main initiators of vascular damage. In this review, I discuss the influence of various types of obesity on the risk of metabolic diseases, and how these diseases increase cardiovascular disease risk.

Citations

Citations to this article as recorded by  
  • Metabolic activity of adipose tissue depots (literature review)
    O. V. Tuzovskaia, A. D. Khudiakova, Yu. I. Ragino
    Siberian Journal of Clinical and Experimental Medicine.2026; 41(1): 47.     CrossRef
  • From bench to bedside: adipose tissue fibrosis in obesity, anti-diabetic therapies, and bariatric surgery
    Mihye Seo, Kyoil Suh, Hyeong Kyu Park, Kae Won Cho
    The Korean Journal of Internal Medicine.2026; 41(2): 210.     CrossRef
  • The association between body mass index and osteoporosis, with consideration of sex differences: a systematic review and dose-response meta-analysis
    Jianping He, Songyue Deng, Guoping Xie, Lipei Bao, Xu Zhao, Yufeng Zhou, Hu Qian, AnSu Wang
    BMC Musculoskeletal Disorders.2026;[Epub]     CrossRef
  • CT-assessed abdominal visceral adiposity and MASLD: a sex-stratified cross-sectional analysis
    Linying Xu, Ting Chen, Yitian Xie, Xueyu Xiang, Yupeng Liu, Chongyong Xu, Shuran Wang
    Frontiers in Nutrition.2026;[Epub]     CrossRef
  • Early-Life Cardiovascular Risk Factor Trajectories and Coronary Artery Calcium Progression in Midlife
    Qing-Yun Hao, Yu-Hong Zeng, Bo-Shui Huang, Zi-Bin Zhan, Jing-Bin Guo, Kun-Hao Bai, Jun Weng, Jing-Wei Gao, Ze-Hua Li
    Mayo Clinic Proceedings.2026;[Epub]     CrossRef
  • Maternal obesity remodels nutrient transport transcriptional programs in early mouse embryonic and extraembryonic cell lineages
    Amalia Caballero, Lijun Chi, Paul Delgado-Olguín
    Molecular Metabolism.2026; 108: 102375.     CrossRef
  • Herbal appetite suppressants used to aid weight loss
    Sonia Malik, Sultana Patel, Dhvani H. Kuntawala, Gael N. N. Neba Ambe, Yannan Jin, Avninder S. Bhambra, Randolph R. J. Arroo
    Phytochemistry Reviews.2025; 24(5): 4219.     CrossRef
  • Impact of non-sugar sweeteners on metabolism beyond sweet taste perception
    Herbert Herzog, Lei Zhang, Luigi Fontana, G. Gregory Neely
    Trends in Endocrinology & Metabolism.2025; 36(6): 563.     CrossRef
  • Fermented soy products: A review of bioactives for health from fermentation to functionality
    Iskandar Azmy Harahap, Joanna Suliburska, Asli Can Karaca, Esra Capanoglu, Tuba Esatbeyoglu
    Comprehensive Reviews in Food Science and Food Safety.2025;[Epub]     CrossRef
  • Ameliorative effects of Asiasarum root and rhizome extract on high fat diet‑induced obesity in mice through regulation of the SIRT1/PGC1α/AMPK pathways in muscle and liver tissues
    Chenzi Lyu, Seok Kang, Haifeng Shao, Dongeun Kim, Hyo Jung
    Molecular Medicine Reports.2025;[Epub]     CrossRef
  • Polystyrene microplastics impair brown and beige adipocyte function via the gut microbiota-adipose tissue crosstalk in high-fat diet mice
    Guangning Kou, Shuai Yao, Amin Ullah, Shuhao Fang, Erni Guo, Yacong Bo
    Journal of Hazardous Materials.2025; 492: 138225.     CrossRef
  • Association of Steatotic Liver Disease with Retinal Vascular Occlusion: The Influence of Obesity in a Large Health Screening Cohort
    Younjin Oh, Su Jeong Song
    Endocrinology and Metabolism.2025; 40(2): 299.     CrossRef
  • Association of cardiometabolic index with gallstone disease and insulin resistance based on NHANES data
    Liu Yuan, Shuqi Wang, Dong Wang, Enbo Wang
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Modulation of Cuproptosis Pathway Genes (DLAT, FDX1) and Antioxidant Enzyme Activities in Obese Mice in Response to Quercetin and Calorie Restriction
    Nima Mahdei Nasirmahalleh, Mina Hemmati, Negin Parsamanesh, Mohammad Borji
    DNA and Cell Biology.2025; 44(7): 370.     CrossRef
  • Lipid accumulation product index is inversely U-shaped associated with abdominal aortic calcification based on NHANES 2013–2014
    Jiangbei Deng, Xiao Qin
    Frontiers in Cardiovascular Medicine.2025;[Epub]     CrossRef
  • Association between lipid accumulation product and visceral adiposity index with endometriosis: evidence from NHANES 1999–2006
    Nan Ma, Yingying Hu, Yan Xu
    BMC Women's Health.2025;[Epub]     CrossRef
  • The relationship between programmed cell death and vascular calcification
    Jie Zheng, Zhengjie Lin, Xiaolin Zhong, Jianghua Liu
    Frontiers in Cardiovascular Medicine.2025;[Epub]     CrossRef
  • A nomogram model combining sarcopenic obesity and biomarkers to predict the risk of vascular stiffness
    Wenwen Liu, Mingyu Zhu, Ziyi Wei, Ningxin Chen, Tingting Han, Ting Zhang, Yurong Weng, Yiling Fan, Yaomin Hu
    Clinical Nutrition ESPEN.2025; 69: 323.     CrossRef
  • Depression mediates the association between lipid accumulation products and overactive bladder
    Caijuan Huang, Ying Xu, Yibing Guan, Jingjing Liu, Haiping Yang
    Scientific Reports.2025;[Epub]     CrossRef
  • Research Hotspots and Trends of Endoplasmic Reticulum Stress in Obesity From 2014 to 2024: A CiteSpace Visualization Analysis
    Xiaotian Zhang, Mengjie Kang, Yuan Cai, Juan jin, Sitong Guo, Yun Liu
    Cureus.2025;[Epub]     CrossRef
  • Research Progress on the Association Between Sarcopenic Obesity and Atherosclerosis: Current Status and Challenges
    Kai Yang, Wei Yang, Si-Cong Si, Jia Liu, Yi-Xin Ma, Huan Zhao
    Journal of Clinical Medicine.2025; 14(22): 8148.     CrossRef
  • Associations of omega-3 fatty acids vs. fenofibrate with adverse cardiovascular outcomes in people with metabolic syndrome: propensity matched cohort study
    Nam Hoon Kim, Ji Yoon Kim, Jimi Choi, Sin Gon Kim
    European Heart Journal - Cardiovascular Pharmacotherapy.2024; 10(2): 118.     CrossRef
  • Severity of abdominal obesity and cardiometabolic diseases in US adults
    S. Wang, S. Shi, Y. Huang, H. Huang, V.W. Zhong
    Public Health.2024; 227: 154.     CrossRef
  • Association between lipid accumulation product and psoriasis among adults: a nationally representative cross-sectional study
    Caiyun Zhang, Xiaoping Dong, Jun Chen, Fang Liu
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Anti-obesity effects of fucoidan from Sargassum thunbergii in adipocytes and high fat diet induced obese mice through inhibiting adipogenic specific transcription factor
    Hyo-Geun Lee, H.H.A.C.K. Jayawardhana, Fengqi Yang, D.P. Nagahawaththa, N.M. Liyanage, Kyung-Mo Song, Yun-Sang Choi, Seung-Hong Lee, You-Jin Jeon, Min-Cheol Kang
    Food Science and Human Wellness.2024; 13(3): 1608.     CrossRef
  • Association of a High Healthy Eating Index Diet with Long-Term Visceral Fat Loss in a Large Longitudinal Study
    Sunmin Park
    Nutrients.2024; 16(4): 534.     CrossRef
  • Ancistrocladus tectorius Extract Inhibits Obesity by Promoting Thermogenesis and Mitochondrial Dynamics in High-Fat Diet-Fed Mice
    Minju Kim, Jin Hyub Paik, Hwa Lee, Min Ji Kim, Sang Mi Eum, Soo Yong Kim, Sangho Choi, Ho-Yong Park, Hye Gwang Jeong, Tae-Sook Jeong
    International Journal of Molecular Sciences.2024; 25(7): 3743.     CrossRef
  • Biological Activity Evaluation of Olive, Grape, and Fig at Various Mixing Ratios
    Chan-Hwi Lee, So-Young Lee, Ae-Jung Kim
    Asian Journal of Beauty and Cosmetology.2024; 22(1): 91.     CrossRef
  • Investigation and Comparison of Maternal Pre-Pregnancy Body Mass Index Coupled with Gestational Weight Gain on Maternal–Fetal Complications Based on US and Chinese Guidelines: A Retrospective Study
    Wan-Ju Kung, Hsin-Yi Kuo, Ching-Feng Chang, Yeong-Hwa Zen, Ching-Chiang Lin
    Reproductive Sciences.2024; 31(8): 2379.     CrossRef
  • Docosahexanoic Acid Attenuates Palmitate-Induced Apoptosis by Autophagy Upregulation via GPR120/mTOR Axis in Insulin-Secreting Cells
    Seok-Woo Hong, Jinmi Lee, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
    Endocrinology and Metabolism.2024; 39(2): 353.     CrossRef
  • Adipokine Modulation in Endometrial Hyperplasia by Polyunsaturated Fatty Acids
    Athuru Supriya, Ammu V. V. V. Ravi Kiran, Praveen Thaggikuppe Krishnamurthy
    Journal of Pharmacology and Pharmacotherapeutics.2024; 15(3): 237.     CrossRef
  • Association of osteoporosis with sarcopenia and its components among community-dwelling older Chinese adults with different obesity levels: A cross-sectional study
    Xing Yu, Yaqing Zheng, Yuewen Liu, Peipei Han, Xiaoyu Chen, Naiwen Zhang, Yejia Ni, Ziyi Zhou, Qi Guo
    Medicine.2024; 103(24): e38396.     CrossRef
  • Association between mixed exposure to per- and polyfluoroalkyl substances and metabolic syndrome in Korean adults: Data from the Korean National environmental health survey cycle 4
    Seung Min Chung, Kyun Hoo Kim, Jun Sung Moon, Kyu Chang Won
    International Journal of Hygiene and Environmental Health.2024; 261: 114427.     CrossRef
  • Advances in the Synthesis and Physiological Metabolic Regulation of Nicotinamide Mononucleotide
    Chuxiong Zheng, Yumeng Li, Xin Wu, Le Gao, Xiaoyi Chen
    Nutrients.2024; 16(14): 2354.     CrossRef
  • Impact of metabolic parameters and risk factors on surfactant proteins SP-A and SP-D in abdominal obesity
    K.Yu. Nikolaev, Ya.K. Lapitskaya, I.A. Kosarev, N.F. Dadashova
    Russian Journal of Preventive Medicine.2024; 27(7): 60.     CrossRef
  • Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study
    Astrid Lavens, Christophe De Block, Philippe Oriot, Laurent Crenier, Jean-Christophe Philips, Michel Vandenbroucke, An-Sofie Vanherwegen, Frank Nobels, Chantal Mathieu
    Diabetologia.2024; 67(12): 2678.     CrossRef
  • Association between lipid accumulation products and gallstones: an analysis of the National Health and Nutrition Examination Survey 2017–2020
    Huimin Wang, Xiaojia Feng, Qihui Huang, Xiaowei Zheng
    BMC Gastroenterology.2024;[Epub]     CrossRef
  • Lipid accumulation product, poverty income ratio, and bone mineral density in U.S. adults: a mediation analysis based on NHANES (2009–2020)
    Zihao Chen, Haobo Ye, Enli Li, Yuzhe Lin, Chen Jin, Lei Yang
    Frontiers in Nutrition.2024;[Epub]     CrossRef
  • Epidemiology and Trends of Obesity and Bariatric Surgery in Korea
    Kyungdo Han, Jin-Hyung Jung, Su-Min Jeong, Mee Kyoung Kim
    Endocrinology and Metabolism.2024; 39(5): 678.     CrossRef
  • Assessment of Paraoxonase 1 and Arylesterase Activities and Lipid Profile in Bodybuilders: A Comparative Study of Physical Activity and Anthropometry on Atherosclerosis
    Hakim Celik, Mehmed Zahid Tuysuz, Yakup Aktas, Mehmet Ali Eren, Recep Demirbag
    Medicina.2024; 60(10): 1717.     CrossRef
  • Evaluation of Health Associations With Height‐Normalised Abdominal Body Composition Indices: A Single‐Centre Cross‐Sectional Study
    Yupeng Liu, Hangqian He, Keyu Qian, Yufeng Huang, Xuemei Ao, Xudong Shi, Binye Ruan, Ru Xue, Xiaoyi Fu, Shuran Wang
    Journal of Cachexia, Sarcopenia and Muscle.2024; 15(6): 2651.     CrossRef
  • Association between lipid accumulation products and stress urinary incontinence: a cross-sectional study from NHANES 2005 to 2018
    JiHang Li, Dong Wang, Hu Tian, JianKun Yang, Hui Xia, WenBin Guo
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Exploring the relationship between trunk flexibility and arterial stiffness measured by pulse wave velocity: A systematic review and meta-analysis
    Iván Cavero-Redondo, Helder Fonseca, Iris Otero-Luis, Lucimere Bohn, Carla Geovanna Lever-Megina, Nerea Moreno-Herraiz, Alicia Saz-Lara, Sebastian Schnaubelt
    PLOS ONE.2024; 19(12): e0311611.     CrossRef
  • Mechanistic insights into dietary (poly)phenols and vascular dysfunction-related diseases using multi-omics and integrative approaches: Machine learning as a next challenge in nutrition research
    Dragan Milenkovic, Tatjana Ruskovska
    Molecular Aspects of Medicine.2023; 89: 101101.     CrossRef
  • Pharmacological Support for the Treatment of Obesity—Present and Future
    Marcin Kosmalski, Kacper Deska, Bartłomiej Bąk, Monika Różycka-Kosmalska, Tadeusz Pietras
    Healthcare.2023; 11(3): 433.     CrossRef
  • Prioritizing obesity treatment: expanding the role of cardiologists to improve cardiovascular health and outcomes
    Donna H. Ryan, John E. Deanfield, Stephan Jacob
    Cardiovascular Endocrinology & Metabolism.2023; 12(1): e0279.     CrossRef
  • Adipopenia is associated with osteoporosis in community-dwelling non-underweight adults independent of sarcopenia
    Seunghyun Lee, Kyoungmyoung Ko, Sungjae Shin, Hye Sun Park, Namki Hong, Yumie Rhee
    Archives of Osteoporosis.2023;[Epub]     CrossRef
  • Design, synthesis and evaluation of 2-pyrimidinylindole derivatives as anti-obesity agents by regulating lipid metabolism
    Shi-Yao Guo, Li-Yuan Wei, Bing-Bing Song, Yu-Tao Hu, Zhi Jiang, Dan-Dan Zhao, Yao-Hao Xu, Yu-Wei Lin, Shu-Min Xu, Shuo-Bin Chen, Zhi-Shu Huang
    European Journal of Medicinal Chemistry.2023; 260: 115729.     CrossRef
  • Short-Term L-Citrulline Supplementation Does Not Affect Blood Pressure, Pulse Wave Reflection, or Arterial Stiffness at Rest and during Isometric Exercise in Older Males
    Andrea Tryfonos, Filippos Christodoulou, George M. Pamboris, Stephanos Christodoulides, Anastasios A. Theodorou
    Sports.2023; 11(9): 177.     CrossRef
  • Skinfold Thickness as a Cardiometabolic Risk Predictor in Sedentary and Active Adult Populations
    Sughey González-Torres, Luis Miguel Anaya-Esparza, Gabriel Fermín Trigueros del Valle, Edgar Alfonso Rivera-León, Zuamí Villagrán, Sergio Sánchez-Enríquez
    Journal of Personalized Medicine.2023; 13(9): 1326.     CrossRef
  • Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study
    Ángel Arturo López-González, Bárbara Altisench Jané, Luis Masmiquel Comas, Sebastiana Arroyo Bote, Hilda María González San Miguel, José Ignacio Ramírez Manent
    Nutrients.2022; 14(14): 2795.     CrossRef
  • Fenofibrate enhances lipid deposition via modulating PPARγ, SREBP-1c, and gut microbiota in ob/ob mice fed a high-fat diet
    Ying Zhang, Xiu-Bin Jia, Yun-Chao Liu, Wen-Qian Yu, Yan-Hong Si, Shou-Dong Guo
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Predictive Roles of Basal Metabolic Rate and Body Water Distribution in Sarcopenia and Sarcopenic Obesity: The link to Carbohydrates
    Lizheng Guan, Tiantian Li, Xuan Wang, Kang Yu, Rong Xiao, Yuandi Xi
    Nutrients.2022; 14(19): 3911.     CrossRef
  • Metabolic risk factors in patients with comorbidity in Ufa primary health care
    O.V. Molchanova, A.V. Mamaeva, A.R. Dunayeva, Z.A. Lust, E.M. Faskhetdinova, R.N. Shepel, D.O. Orlov, L.M. Zhamalov, G.F. Andreeva, O.M. Drapkina
    Profilakticheskaya meditsina.2022; 25(9): 39.     CrossRef
  • Assessment of Vitamin D Levels in Relation to Statin Therapy in Elderly Hypertensive Patients with Comorbidities
    Kinga-Ilona Nyulas, Zsuzsánna Simon-Szabó, Zoltán Preg, Sándor Pál, Arundhati Sharma, Tünde Pál, Márta Germán-Salló, Enikő Nemes-Nagy
    Journal of Interdisciplinary Medicine.2022; 7(4): 88.     CrossRef
Close layer
Original Articles
Diabetes, Obesity and Metabolism
The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE−/−FXR−/− Mice
Yenna Lee, Bo-Rahm Kim, Geun-Hyung Kang, Gwan Jae Lee, Young Joo Park, Haeryoung Kim, Hak Chul Jang, Sung Hee Choi
Endocrinol Metab. 2021;36(6):1243-1253.   Published online December 28, 2021
DOI: https://doi.org/10.3803/EnM.2021.1100
  • 12,422 View
  • 191 Download
  • 31 Web of Science
  • 33 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Farnesoid X receptor (FXR), a bile acid–activated nuclear receptor, is a potent regulator of glucose and lipid metabolism as well as of bile acid metabolism. Previous studies have demonstrated that FXR deficiency is associated with metabolic derangements, including atherosclerosis and nonalcoholic fatty liver disease (NAFLD), but its mechanism remains unclear. In this study, we investigated the role of FXR in atherosclerosis and NAFLD and the effect of peroxisome proliferator-activated receptor (PPAR) agonists in mouse models with FXR deficiency.
Methods
En face lipid accumulation analysis, liver histology, serum levels of glucose and lipids, and mRNA expression of genes related to lipid metabolism were compared between apolipoprotein E (ApoE)−/− and ApoE−/−FXR−/− mice. The effects of PPARα and PPARγ agonists were also compared in both groups of mice.
Results
Compared with ApoE−/− mice, ApoE−/−FXR−/− mice showed more severe atherosclerosis, hepatic steatosis, and higher levels of serum cholesterol, low-density lipoprotein cholesterol, and triglycerides, accompanied by increased mRNA expression of FAS, ApoC2, TNFα, IL-6 (liver), ATGL, TGH, HSL, and MGL (adipocytes), and decreased mRNA expressions of CPT2 (liver) and Tfam (skeletal muscle). Treatment with a PPARα agonist, but not with a PPARγ agonist, partly reversed atherosclerosis and hepatic steatosis, and decreased plasma triglyceride levels in the ApoE−/−FXR−/− mice, in association with increased mRNA expression of CD36 and FATP and decreased expression of ApoC2 and ApoC3 (liver).
Conclusion
Loss of FXR is associated with aggravation of atherosclerosis and hepatic steatosis in ApoE-deficient mice, which could be reversed by a PPARα agonist through induction of fatty acid uptake, β-oxidation, and triglyceride hydrolysis.

Citations

Citations to this article as recorded by  
  • Evaluation of the causal effects of PFOS on atherosclerosis and its potential toxicological mechanisms: Integrated Mendelian randomization and network toxicology analysis
    Cong Yan, Ning Fang, Yongtai Gong
    Ecotoxicology and Environmental Safety.2026; 309: 119618.     CrossRef
  • Time-Restricted Dietary Intervention as a Metabolic Regulator in Type 2 Diabetes Mellitus: A Systematic Review of Evidence From Human and Rodent Studies
    Bavani Visha Doraisamy, Joyce Argaistieng, Siti Saleha Masrudin, Nurul Izzati Uda Zahli, Aida Azlina Ali, Sandra Maniam
    Nutrition Reviews.2026;[Epub]     CrossRef
  • Effects of bulevirtide on atherosclerosis in an ApoE-deficient mouse model
    Jonas Rusnak, Victoria Delcheva, Dirk Theile, Antje Blank, Norbert Frey, Michael R. Preusch, Lanlan Chen
    PLOS One.2026; 21(5): e0349211.     CrossRef
  • PCSK9 with a gain of function D374Y mutation aggravates atherosclerosis by inhibiting PPARα expression
    Yuan feng Cui, Xiao cui Chen, Tuoluonayi Mijiti, Abidan Abudurusuli, Li hui Deng, Xiang Ma, Bangdang Chen
    Scientific Reports.2025;[Epub]     CrossRef
  • Calycosin improves atherosclerosis by reshaping the interaction between the gut microbiome and bile acid metabolism
    Jiaqi Fu, Donghua Yu, Yuqin Liang, Xin Gao, Yunhe Shi, Yu Wang, Pingping Chen, Fang Lu, Shumin Liu
    Food Science and Human Wellness.2025; 14(4): 9250085.     CrossRef
  • Restoring FXR expression as a novel treatment strategy in liver cancer and other liver disorders
    Sosmitha Girisa, Babu Santha Aswani, Mukesh Kumar Manickasamy, Mangala Hegde, Mohammed S. Alqahtani, Mohamed Abbas, Gautam Sethi, Ajaikumar B. Kunnumakkara
    Expert Opinion on Therapeutic Targets.2025; 29(4-5): 193.     CrossRef
  • Targeted drug delivery systems for atherosclerosis
    Liangxing Tu, Zijian Zou, Ye Yang, Siying Wang, Banghuai Xing, Jianfang Feng, Yi Jin, Meng Cheng
    Journal of Nanobiotechnology.2025;[Epub]     CrossRef
  • Interplay of the pathophysiological mechanisms of non-alcoholic fatty liver disease, diabetes mellitus, and inflammation: A growing threat to public health
    Sharon Olabisoye Oladipupo, Emmanuel Henry Ezenabor, Adebola Busola Ojo, Akingbolabo Daniel Ogunlakin, Oluwafemi Adeleke Ojo
    Obesity Medicine.2025; 55: 100613.     CrossRef
  • Farnesoid X receptor‑driven metabolic plasticity: Bridging physiological adaptation and malignant transformation in lipid handling (Review)
    Yanning Sun, Kai Sun, Hongju Ling, Qinghua Xia
    International Journal of Molecular Medicine.2025; 56(1): 1.     CrossRef
  • Advances of exosome regulating‑FXR to repair inflammatory bowel disease (Review)
    Peter Muro, Caihong Jing, Yaru Qiao, Wenbing Wang, Bo Wang, Fei Mao
    International Journal of Molecular Medicine.2025; 56(3): 1.     CrossRef
  • Impact of smoking and physical activity on cardiovascular outcomes in type 2 diabetes across steatotic liver disease categories
    So Hyun Cho, Gyuri Kim, Kyu-na Lee, Rosa Oh, Ji Yoon Kim, Myunghwa Jang, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Kyungdo Han, Jae Hyeon Kim
    Scientific Reports.2025;[Epub]     CrossRef
  • Exercise in atherosclerosis: its beneficial effects and underlying mechanism
    Meng-ting Yin, Liang Guo
    Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
  • Investigating the Effects of Curcumin on Lipid Metabolism and Cell Viability in HepG2 Cells: Potential Therapeutic Implications for Nonalcoholic Fatty Liver Disease
    Faeze Qaleban, Javad Mohammadnejad, Amin Daemi, Gülüzar Özbolat, Yusuf Döğüş
    Drug Development Research.2025;[Epub]     CrossRef
  • Nuclear receptors in metabolic, inflammatory, and oncologic diseases: mechanisms, therapeutic advances, and future directions
    Mohammed A. Abdel-Rasol, Wael M. El-Sayed
    European Journal of Medical Research.2025;[Epub]     CrossRef
  • Effect of 3-hydroxyisobutyrate in vivo administration on cardiometabolic disease in ApoE-/- mouse model
    Viviana Casagrande, Luca Panarello, Alessio Lepri, Andrea Quatrana, Chiara Internò, Lorenzo Antonetti, Elena Bonanno, Ilaria Cicalini, Damiana Pieragostino, Andrea Gorgels, Vincenzo De Laurenzi, Claudia Goettsch, Marina Cardellini, Massimo Federici, Rosse
    Pharmacological Research.2025; 220: 107943.     CrossRef
  • Zhuriheng pills improve adipose tissue dysfunction and inflammation by modulating PPARγ to stabilize atherosclerotic plaques
    Qiong Zhai, Fangyuan Liang, Guanlin Yang, Zhimin Liu, Xin Dong, Ren Bu, Peifeng Xue, Shengsang Na, Xuan Zhang, Pengwei Zhao, Xiaoning Wang, Qiang Wei, Yuewu Wang, Jingkun Lu
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Analysis of the Correlation Between Cuproptosis and Instability of Atherosclerotic Plaques
    Muheremu Muhetaer, Tianwen He, Haoyan Zhu, Jiahe Wu, Jingjing Wan, Tong Zhang, Yushuang Hu, Zhibing Lu, Huanhuan Cai
    Biomedicines.2025; 13(12): 2983.     CrossRef
  • Evaluation of the hepatotoxicity of Psoralea corylifolia L. based on a zebrafish model
    Shu-Yan Gao, Jing-Cheng Zhao, Qing Xia, Chen Sun, Maimaiti Aili, Ainiwaer Talifu, Shi-Xia Huo, Yun Zhang, Zhi-Jian Li
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
    Yuxiao Jiang, Lili Wu, Xiaopeng Zhu, Hua Bian, Xin Gao, Mingfeng Xia
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
    Inha Jung, Dae-Jeong Koo, Won-Young Lee
    Diabetes & Metabolism Journal.2024; 48(3): 327.     CrossRef
  • Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease
    Milton Boaheng Antwi, Ariann Jennings, Sander Lefere, Dorien Clarisse, Anja Geerts, Lindsey Devisscher, Karolien De Bosscher
    npj Metabolic Health and Disease.2024;[Epub]     CrossRef
  • Monomethyl Branched‐Chain Fatty Acids Suppress M1 Macrophage Polarization via FABP4/PPAR‐γ Signaling Pathway
    Yuan He, Yu Zhang, Shuang Zhu, Yuan‐fa Liu, Sha Liu, Yong‐jiang Xu
    Molecular Nutrition & Food Research.2024;[Epub]     CrossRef
  • COL6A6 Peptide Vaccine Alleviates Atherosclerosis through Inducing Immune Response and Regulating Lipid Metabolism in Apoe−/− Mice
    Dongmei Tang, Yan Liu, Rui Duan, Run Lin, Zhonghao Li, Xianyan Liu, Jingrong Huang, Ming Zhao
    Cells.2024; 13(18): 1589.     CrossRef
  • Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis
    Min Yao, Ping Zhou, Yan-Yan Qin, Li Wang, Deng-Fu Yao
    World Journal of Gastroenterology.2023; 29(12): 1765.     CrossRef
  • Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases
    Tess Yntema, Debby P. Y. Koonen, Folkert Kuipers
    Nutrients.2023; 15(8): 1850.     CrossRef
  • The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
    Alexandra C. Finney, Sandeep Das, Dhananjay Kumar, M. Peyton McKinney, Bishuang Cai, Arif Yurdagul, Oren Rom
    Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • Targeting PPARs for therapy of atherosclerosis: A review
    Miao Miao, Xue Wang, Tian Liu, Yan-Jie Li, Wen-Qian Yu, Tong-Mei Yang, Shou-Dong Guo
    International Journal of Biological Macromolecules.2023; 242: 125008.     CrossRef
  • Cabernet sauvignon dry red wine ameliorates atherosclerosis in mice by regulating inflammation and endothelial function, activating AMPK phosphorylation, and modulating gut microbiota
    Xinlong Cheng, Xue Han, Liangfu Zhou, Yasai Sun, Qian Zhou, Xuan Lin, Zhe Gao, Jie Wang, Wen Zhao
    Food Research International.2023; 169: 112942.     CrossRef
  • Impacts of dietary lipids derived from animal or vegetable sources on healthy rats
    Mostafa M Dalal, Gamal M Edrees, Hanaa A Hassan, Mamdouh Abdel-Mogib, Mai Alaa El-Dein
    Egyptian Journal of Basic and Applied Sciences.2023; 10(1): 618.     CrossRef
  • Whey protein hydrolysate alleviated atherosclerosis and hepatic steatosis by regulating lipid metabolism in apoE-/- mice fed a Western diet
    Kai Wang, Zixin Fu, Xiaoyi Li, Hui Hong, Xin Zhan, Xiaohong Guo, Yongkang Luo, Yuqing Tan
    Food Research International.2022; 157: 111419.     CrossRef
  • Melatonin alleviates PM2.5‐induced glucose metabolism disorder and lipidome alteration by regulating endoplasmic reticulum stress
    Zhou Du, Junjie Hu, Lisen Lin, Qingqing Liang, Mengqi Sun, Zhiwei Sun, Junchao Duan
    Journal of Pineal Research.2022;[Epub]     CrossRef
  • Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia
    Joon Ho Moon, Kyuho Kim, Sung Hee Choi
    Endocrinology and Metabolism.2022; 37(4): 575.     CrossRef
  • The role of the gut microbiota in health and cardiovascular diseases
    Lu Wang, Shiqi Wang, Qing Zhang, Chengqi He, Chenying Fu, Quan Wei
    Molecular Biomedicine.2022;[Epub]     CrossRef
Close layer
Endocrine Research
Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model
Jin Hee Kim, Gha Young Lee, Hyo Jin Maeng, Hoyoun Kim, Jae Hyun Bae, Kyoung Min Kim, Soo Lim
Endocrinol Metab. 2021;36(1):157-170.   Published online February 24, 2021
DOI: https://doi.org/10.3803/EnM.2020.781
  • 14,117 View
  • 216 Download
  • 26 Web of Science
  • 29 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Glucagon-like peptide-1 (GLP-1) analogues regulate glucose homeostasis and have anti-inflammatory properties, but cause gastrointestinal side effects. The fibroblast growth factor 21 (FGF21) is a hormonal regulator of lipid and glucose metabolism that has poor pharmacokinetic properties, including a short half-life. To overcome these limitations, we investigated the effect of a low-dose combination of a GLP-1 analogue and FGF21 on atherosclerosis-related molecular pathways.
Methods
C57BL/6J mice were fed a high-fat diet for 30 weeks followed by an atherogenic diet for 10 weeks and were divided into four groups: control (saline), liraglutide (0.3 mg/kg/day), FGF21 (5 mg/kg/day), and low-dose combination treatment with liraglutide (0.1 mg/kg/day) and FGF21 (2.5 mg/kg/day) (n=6/group) for 6 weeks. The effects of each treatment on various atherogenesisrelated pathways were assessed.
Results
Liraglutide, FGF21, and their low-dose combination significantly reduced atheromatous plaque in aorta, decreased weight, glucose, and leptin levels, and increased adiponectin levels. The combination treatment upregulated the hepatic uncoupling protein-1 (UCP1) and Akt1 mRNAs compared with controls. Matric mentalloproteinase-9 (MMP-9), monocyte chemoattractant protein-1 (MCP-1), and intercellular adhesion molecule-1 (ICAM-1) were downregulated and phosphorylated Akt (p-Akt) and phosphorylated extracellular signal-regulated kinase (p-ERK) were upregulated in liver of the liraglutide-alone and combination-treatment groups. The combination therapy also significantly decreased the proliferation of vascular smooth muscle cells. Caspase-3 was increased, whereas MMP-9, ICAM-1, p-Akt, and p-ERK1/2 were downregulated in the liraglutide-alone and combination-treatment groups.
Conclusion
Administration of a low-dose GLP-1 analogue and FGF21 combination exerts beneficial effects on critical pathways related to atherosclerosis, suggesting the synergism of the two compounds.

Citations

Citations to this article as recorded by  
  • Engineered Elastin‐Like Polypeptides: Intelligent Self‐Assembling Platforms for Biomedical Application
    Yang Yuan, Chen Zeng, Zichun Chen, Zhuoga Ciren, Qinran Yu, Chuanbo Wang, Hui Mao, Gang Li, Weizhi Chen, Xiqun Jiang
    Small Structures.2026;[Epub]     CrossRef
  • Direct or Indirect Action? Mechanisms of the Antiatherosclerotic Effects of Glucagon‐Like Peptide‐1 Receptor Agonists
    Michał Zawadzki, Monika Karczewska-Kupczewska, Arquimedes Gasparotto Junior
    Cardiovascular Therapeutics.2026;[Epub]     CrossRef
  • Metabolic state determines the brain and direct islet effects of liraglutide on enhanced insulin secretion
    Chiara Saponaro, Monica Imbernon, Isaline Louvet, Eleonora Deligia, Shiqian Chen, Iona Davies, Ana Acosta-Montalvo, Maria Moreno-Lopez, Eve Wemelle, Lakshmi Kothegala, Begoña Porteiro, Florent Auger, Lorea Zubiaga, Nathalie Dellalau, Julien Thevenet, Mark
    Diabetologia.2026;[Epub]     CrossRef
  • GLP-1 receptor agonism reduces PTSD-like anxiety and alters amygdala–hippocampal activity patterns in a Chemogenetic mouse model
    Kubra Akillioglu, Seda Kose Korkmaz, Meltem Donmez Kutlu, Tugce Sapmaz Ercakallı, Leman Sencar
    Progress in Neuro-Psychopharmacology and Biological Psychiatry.2026; 148: 111804.     CrossRef
  • Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
    Zara Siu Wa Chui, Yaqian Xue, Xiaoping Wu, Aimin Xu
    Pharmacological Reviews.2026; : 100150.     CrossRef
  • Inflammasome-Driven Cardiac Fibrosis in Cardiometabolic Disease and Arrhythmias: Mechanisms, Biomarkers, and Therapeutic Targets
    Konstantinos Grigoriou, Vasileios Lamprou, Antonios P Antoniadis, Panagiotis Theofilis, Panagiotis Iliakis, Nikolaos Ktenopoulos, Anastasios Apostolos, Athina Nasoufidou, Barbara Fyntanidou, Efstratios Karagiannidis, Nikolaos Fragakis, Dimitrios Patoulias
    Frontiers in Bioscience-Landmark.2026;[Epub]     CrossRef
  • Vutiglabridin overcomes the GLP-1 RA-associated weight-loss plateau to achieve normal body weight
    Hyeong Min Lee, Kamindu Gayashan Marakkalage, Sang Hyo Kim, Soonje Lee, Jae Ho Lee, Hyung Soon Park, Sang-Ku Yoo
    International Journal of Obesity.2026;[Epub]     CrossRef
  • Clonal Hematopoiesis of Indeterminate Potential and Atrial Fibrillation: Insights into Pathophysiology and Clinical Implications
    Paschalis Karakasis, Panagiotis Theofilis, Eleftheria Lefkou, Antonios P. Antoniadis, Dimitrios Patoulias, Panagiotis Korantzopoulos, Nikolaos Fragakis
    International Journal of Molecular Sciences.2025; 26(6): 2739.     CrossRef
  • Therapeutic effects and mechanistic insights of YiQiHuangDou decoction on high-fat diet-induced obesity-related Glomerulopathy (ORG) in mice
    Xiaoxiao Liu, Longfei Zhang, Mingze Xu, Ning Li, Canfeng Bian, Linlin Hu, Wenlong Ma, Dawei Chen, Tianzhu Guan, Lixia Xiao
    Journal of Functional Foods.2025; 127: 106728.     CrossRef
  • Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease Modulation
    Merita Rroji, Nereida Spahia, Andreja Figurek, Goce Spasovski
    Biomedicines.2025; 13(3): 728.     CrossRef
  • Atrial Cardiomyopathy in Atrial Fibrillation: Mechanistic Pathways and Emerging Treatment Concepts
    Paschalis Karakasis, Panagiotis Theofilis, Panayotis K. Vlachakis, Nikolaos Ktenopoulos, Dimitrios Patoulias, Antonios P. Antoniadis, Nikolaos Fragakis
    Journal of Clinical Medicine.2025; 14(9): 3250.     CrossRef
  • Imo-induced changes in gut hormones and glucose metabolism: A key to improving insulin sensitivity in type 2 diabetes
    Sobia Naseem, Muhammad Rizwan
    Diabetes Research and Clinical Practice.2025; 226: 112285.     CrossRef
  • Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies
    Konstantinos Grigoriou, Paschalis Karakasis, Konstantinos Pamporis, Panagiotis Theofilis, Dimitrios Patoulias, Efstratios Karagiannidis, Barbara Fyntanidou, Antonios P. Antoniadis, Nikolaos Fragakis
    Current Issues in Molecular Biology.2025; 47(7): 559.     CrossRef
  • Research progress on the role of FGF21 in insulin resistance
    Haixin Zhang, Rongyu Zhu, Quanhao Sun, Likun Du
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Comprehensive phytochemical mapping and biomedical evaluation of Lawsonia inermis L: a potential natural treatment for diabetic foot ulcers with wound healing and antimicrobial effects
    Safaa M. Kotb, Mai M. Farid, Ahmed A. Al-Karmalawy, Magdy A.H. Zahran, Briksam S. Mohamed, Abdelnaser A. Gadallah, Bishoy El-Aarag
    Fitoterapia.2025; 187: 106939.     CrossRef
  • Arrhythmia-Induced Cardiomyopathy in Atrial Fibrillation: Pathogenesis, Diagnosis, and Treatment
    Paschalis Karakasis, Panagiotis Theofilis, Panayotis K. Vlachakis, Anastasios Apostolos, Nikolaos Ktenopoulos, Konstantinos Grigoriou, Dimitrios Patoulias, Antonios P. Antoniadis, Nikolaos Fragakis
    Life.2025; 15(11): 1675.     CrossRef
  • Current status and future perspectives of FGF21 analogues in clinical trials
    Zara Siu Wa Chui, Qing Shen, Aimin Xu
    Trends in Endocrinology & Metabolism.2024; 35(5): 371.     CrossRef
  • Hepatokines and MASLD: The GLP1-Ras-FGF21-Fetuin-A Crosstalk as a Therapeutic Target
    Ilaria Milani, Michela Codini, Gloria Guarisco, Marianna Chinucci, Chiara Gaita, Frida Leonetti, Danila Capoccia
    International Journal of Molecular Sciences.2024; 25(19): 10795.     CrossRef
  • Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets
    Paschalis Karakasis, Panagiotis Theofilis, Panayotis K. Vlachakis, Panagiotis Korantzopoulos, Dimitrios Patoulias, Antonios P. Antoniadis, Nikolaos Fragakis
    International Journal of Molecular Sciences.2024; 26(1): 209.     CrossRef
  • Design and pharmaceutical evaluation of bifunctional fusion protein of FGF21 and GLP-1 in the treatment of nonalcoholic steatohepatitis
    Xianlong Ye, Yingli Chen, Jianying Qi, Shenglong Zhu, Yuanyuan Wu, Jingjing Xiong, Fei Hu, Zhimou Guo, Xinmiao Liang
    European Journal of Pharmacology.2023; 952: 175811.     CrossRef
  • Use of FGF21 analogs for the treatment of metabolic disorders: a systematic review and meta-analysis
    Maria Paula Carbonetti, Fernanda Almeida-Oliveira, David Majerowicz
    Archives of Endocrinology and Metabolism.2023;[Epub]     CrossRef
  • Exploring the potential mechanism of Simiao Yongan decoction in the treatment of diabetic peripheral vascular disease based on network pharmacology and molecular docking technology
    Fang Cao, Yongkang Zhang, Yuan Zong, Xia Feng, Junlin Deng, Yuzhen Wang, Yemin Cao
    Medicine.2023; 102(52): e36762.     CrossRef
  • The Healing Capability of Clove Flower Extract (CFE) in Streptozotocin-Induced (STZ-Induced) Diabetic Rat Wounds Infected with Multidrug Resistant Bacteria
    Rewaa Ali, Tarek Khamis, Gamal Enan, Gamal El-Didamony, Basel Sitohy, Gamal Abdel-Fattah
    Molecules.2022; 27(7): 2270.     CrossRef
  • Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs
    Eleftheria Galatou, Elena Mourelatou, Sophia Hatziantoniou, Ioannis S. Vizirianakis
    Antioxidants.2022; 11(6): 1060.     CrossRef
  • Unlocking the Therapeutic Potential of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination for the Pathogenesis of Atherosclerosis in Type 2 Diabetes
    Jang Won Son
    Endocrinology and Metabolism.2021; 36(1): 57.     CrossRef
  • Effects of fasting on skeletal muscles and body fat of adult and old C57BL/6J mice
    Mindaugas Kvedaras, Petras Minderis, Leonardo Cesanelli, Agne Cekanauskaite, Aivaras Ratkevicius
    Experimental Gerontology.2021; 152: 111474.     CrossRef
  • The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms
    Mengjie Xiao, Yufeng Tang, Shudong Wang, Jie Wang, Jie Wang, Yuanfang Guo, Jingjing Zhang, Junlian Gu
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Liraglutide Decreases Liver Fat Content and Serum Fibroblast Growth Factor 21 Levels in Newly Diagnosed Overweight Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
    Xinyue Li, Xiaojuan Wu, Yumei Jia, Jing Fu, Lin Zhang, Tao Jiang, Jia Liu, Guang Wang, Claudia Cardoso
    Journal of Diabetes Research.2021; 2021: 1.     CrossRef
  • Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide
    Brent A. McLean, Chi Kin Wong, Kiran Deep Kaur, Randy J. Seeley, Daniel J. Drucker
    JCI Insight.2021;[Epub]     CrossRef
Close layer
Review Article
Diabetes, Obesity and Metabolism
Recent Updates on Vascular Complications in Patients with Type 2 Diabetes Mellitus
Chan-Hee Jung, Ji-Oh Mok
Endocrinol Metab. 2020;35(2):260-271.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.260
  • 12,973 View
  • 309 Download
  • 21 Web of Science
  • 23 Crossref
AbstractAbstract PDFPubReader   ePub   
It is well known that patients with type 2 diabetes mellitus (T2DM) are at an increased risk of morbidity and mortality from atherosclerotic cardiovascular (CV) complications. Previously, the concept that diabetes mellitus (DM) is a “coronary artery disease (CAD) risk equivalent” was widely accepted, implying that all DM patients should receive intensive management. However, considerable evidence exist for wide heterogeneity in the risk of CV events among T2DM patients and the concept of a “CAD risk equivalent” has changed. Recent guidelines recommend further CV risk stratification in T2DM patients, with treatment tailored to the risk level. Although imaging modalities for atherosclerotic cardiovascular disease (ASCVD) have been used to improve risk prediction, there is currently no evidence that imaging-oriented therapy improves clinical outcomes. Therefore, controversy remains whether we should screen for CVD in asymptomatic T2DM. The coexistence of T2DM and heart failure (HF) is common. Based on recent CV outcome trials, sodium glucose cotransporter-2 inhibitors and glucagon like peptide-1 receptor agonists are recommended who have established ASCVD, indicators of high risk, or HF because of their demonstrated benefits for CVD. These circumstances have led to an increasing emphasis on ASCVD and HF in T2DM patients. In this review, we examine the literature published within the last 5 years on the risk assessment of CVD in asymptomatic T2DM patients. In particular, we review recent guidelines regarding screening for CVD and research focusing on the role of coronary artery calcium, coronary computed tomography angiography, and carotid intima-media thickness in asymptomatic T2DM patients.

Citations

Citations to this article as recorded by  
  • Sustained alogliptin elicits superior control of glycemia and related complications in diabetic rats: Effects on vital organs functions, biochemistry, and structure
    Mariam Mohamedy Eladawy, Hany M. El-Bassossy, Shaimaa S. El-Sayed
    European Journal of Pharmacology.2026; 1016: 178614.     CrossRef
  • Serum testosterone and cardiometabolic risk in Nigerian men with type 2 diabetes: a cross−sectional study
    Ezekiel Musa, Esteban Salazar-Petres, Glory Chinuru Musa, Fatima Bello, Adamu Girei Bakari
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Progress in Evaluation of Brain Structural Changes in Type 2 Diabetes Mellitus Complicated with Cognitive Impairment by Magnetic
    贤贤 周
    Advances in Clinical Medicine.2025; 15(01): 1281.     CrossRef
  • Predictive value of uric acid to albumin ratio for carotid atherosclerosis in type 2 diabetes mellitus: A retrospective study
    Yao Yin, Liyin Zhang, Jiaoyue Zhang, Si Jin, Aleksandra Klisic
    PLOS ONE.2025; 20(3): e0320738.     CrossRef
  • Predictive Value of Left Atrial Structure and Function Parameters in Left Ventricular Remodeling in Patients With Type 2 Diabetes Mellitus
    Yumeng Xing, Rui Zhao, Xiaoli Zhang, Jiamei Jin, Yiming Yang, Haier Wang, Yan Wang, Chunyan Zhong, Lin Chen, Yinjia Zhang
    Echocardiography.2025;[Epub]     CrossRef
  • The association between liver function tests abnormalities and type 2 diabetes mellitus patients in Saudi Arabia: a cross-sectional study
    Nimer Mehyar, Ziyad Alhajeri, Muath Alosaimi, Ziyad Alanazi, Abdulkarim Alanazi, Raghib Abusaris
    Frontiers in Clinical Diabetes and Healthcare.2025;[Epub]     CrossRef
  • Mechanistic Insights Into the Cardioprotective Effects of Modern Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review
    Mounica Ratnala, Loveleen K Johal, Zulaihat F Galadima, Fatima F Janjua, Katherine S Trejos Guzman, Kirshan Lal, Maryam Fatima, Mashal Khan, Maryem Mallick, Sunil Yadav, Muhammad Usman Sarwar, Riaz Khan
    Cureus.2025;[Epub]     CrossRef
  • Nonlinear association between high-density lipoprotein cholesterol and carotid atherosclerosis risk in patients with type 2 diabetes: a retrospective analysis from China
    Changchun Cao, Yuzhi Zheng, Fubing Zha, Yong Han, Haofei Hu, Meiling Huang
    European Journal of Medical Research.2025;[Epub]     CrossRef
  • Associations between neutrophil-lymphocyte ratio with all-cause mortality, major adverse vascular events and progression of diabetic kidney disease in type 2 diabetes mellitus
    Ying Jie Chee, Xiaoe Doris Zhang, Rinkoo Dalan
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Factors Affecting Arterial Stiffness and Brachial-Ankle Pulse Wave Velocity in Patients With Type 2 Diabetes
    Tomoki Furuya, Shinji Kitahama, Yuma Tamura, Susumu Ogawa, Yuki Nakatani, Takanori Yasu
    Cureus.2024;[Epub]     CrossRef
  • Serum levels of soluble receptor activator for nuclear factor kB ligand play a crucial role in the association of osteoprotegerin with coronary artery disease
    Shaoqiong Zhou, Hui Wen, Bin Wang, Siming Guan, Xin Fang
    Experimental and Therapeutic Medicine.2024;[Epub]     CrossRef
  • Significance of Myocardial Perfusion SPECT (Single-Photon Emission Computed Tomography) Imaging in the Detection of Silent Myocardial Ischemia in Type II Diabetic Patients with Microalbuminuria
    Nayyar Rubab, Muhammad Ijaz Khan, Tania Jabbar, Warda Ahmed, Farkhanda Gillani, Muhammad Shehzad Afzal, Muhammad Iftikhar Khattak, Muhammad Babar Imran
    Pakistan BioMedical Journal.2024; : 17.     CrossRef
  • Pathways of Coagulopathy and Inflammatory Response in SARS-CoV-2 Infection among Type 2 Diabetic Patients
    Orsolya-Zsuzsa Akácsos-Szász, Sándor Pál, Kinga-Ilona Nyulas, Enikő Nemes-Nagy, Ana-Maria Fárr, Lóránd Dénes, Mónika Szilveszter, Erika-Gyöngyi Bán, Mariana Cornelia Tilinca, Zsuzsánna Simon-Szabó
    International Journal of Molecular Sciences.2023; 24(5): 4319.     CrossRef
  • Increased soluble endoglin levels in newly-diagnosed type 2 diabetic patients are associated with endothelial dysfunction
    Xiaobing Dou, Xiujing Wang, Xiuhua Yu, Jiaqi Yao, Huiling Shen, Yao Xu, Bojing Zheng, Zhenying Zhang, Qingying Tan, Tianxiao Hu
    Endocrine Journal.2023; 70(7): 711.     CrossRef
  • Effects of hypertension on subcortical nucleus morphological alternations in patients with type 2 diabetes
    Feng Cui, Zhi-Qiang Ouyang, Yi-Zhen Zeng, Bing-Bing Ling, Li Shi, Yun Zhu, He-Yi Gu, Wan-Lin Jiang, Ting Zhou, Xue-Jin Sun, Dan Han, Yi Lu
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Coronary Artery Calcium Score as a Sensitive Indicator of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus: A Long-Term Cohort Study
    Dae-Jeong Koo, Mi Yeon Lee, Sun Joon Moon, Hyemi Kwon, Sang Min Lee, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki Won Oh, Sung Rae Cho, Young-Hoon Jeong, Eun-Jung Rhee
    Endocrinology and Metabolism.2023; 38(5): 568.     CrossRef
  • Exploring Endothelial Colony-Forming Cells to Better Understand the Pathophysiology of Disease: An Updated Review
    Qiuwang Zhang, Anthony Cannavicci, Michael J. B. Kutryk, Giuseppe Mandraffino
    Stem Cells International.2022; 2022: 1.     CrossRef
  • Recent Insights into the Nutritional Antioxidant Therapy in Prevention and Treatment of Diabetic Vascular Complications: A Comprehensive Review
    Narasimha M. Beeraka, Irina K. Tomilova, Galina A. Batrak, Maria V. Zhaburina, Vladimir N. Nikolenko, Mikhail Y. Sinelnikov, Liudmila M. Mikhaleva
    Current Medicinal Chemistry.2022; 29(11): 1920.     CrossRef
  • Topical Reappraisal of Molecular Pharmacological Approaches to Endothelial Dysfunction in Diabetes Mellitus Angiopathy
    Constantin Munteanu, Mariana Rotariu, Marius-Alexandru Turnea, Aurelian Anghelescu, Irina Albadi, Gabriela Dogaru, Sînziana Calina Silișteanu, Elena Valentina Ionescu, Florentina Carmen Firan, Anca Mirela Ionescu, Carmen Oprea, Gelu Onose
    Current Issues in Molecular Biology.2022; 44(8): 3378.     CrossRef
  • Visfatin is negatively associated with coronary artery lesions in subjects with impaired fasting glucose
    Fei Xu, Xiang Ning, Tong Zhao, Qinghua Lu, Huiqiang Chen
    Open Medicine.2022; 17(1): 1405.     CrossRef
  • Effects of dulaglutide on endothelial progenitor cells and arterial elasticity in patients with type 2 diabetes mellitus
    Dandan Xie, Yutong Li, Murong Xu, Xiaotong Zhao, Mingwei Chen
    Cardiovascular Diabetology.2022;[Epub]     CrossRef
  • Serum netrin and VCAM-1 as biomarker for Egyptian patients with type IΙ diabetes mellitus
    Maher M. Fadel, Faten R. Abdel Ghaffar, Shimaa K. Zwain, Hany M. Ibrahim, Eman AE. badr
    Biochemistry and Biophysics Reports.2021; 27: 101045.     CrossRef
  • Decoding the chemical composition and pharmacological mechanisms of Jiedu Tongluo Tiaogan Formula using high-performance liquid chromatography coupled with network pharmacology-based investigation
    Qi Zhang, Chunli Piao, Wenqi Jin, De Jin, Han Wang, Cheng Tang, Xiaohua Zhao, Naiwen Zhang, Shengnan Gao, Fengmei Lian
    Aging.2021; 13(21): 24290.     CrossRef
Close layer
Original Article
Clinical Study
Associations of Perirenal Fat Thickness with Renal and Systemic Calcified Atherosclerosis
Bo Kyung Koo, Julie O. Denenberg, C. Michael Wright, Michael H. Criqui, Matthew A. Allison
Endocrinol Metab. 2020;35(1):122-131.   Published online March 19, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.1.122
  • 11,239 View
  • 132 Download
  • 18 Web of Science
  • 18 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

We investigated associations between perirenal fat thickness and atherosclerotic calcification in six different vascular beds.

Methods

Using a community-based cohort (n=3,919), perirenal fat thickness was estimated from computed tomography scans. It was classified as Q1 (the lowest quartile) to Q4 (the highest quartile) in each sex. Calcification in the carotid arteries, coronary arteries, thoracic aorta, abdominal aorta, iliac arteries, and renal arteries was evaluated.

Results

Perirenal fat thickness was associated with older age (P<0.01) and a higher prevalence of obesity, hypertension, and dyslipidemia (P<0.01 for all). Perirenal fat thickness was independently associated with renal arterial calcification even after adjustment for age, sex, body mass index, hypertension, dyslipidemia, smoking history, and family history of heart diseases in first-degree relatives (odds ratio [OR] per quartile of perirenal fat thickness, 1.25; 95% confidence interval [CI], 1.09 to 1.44). Compared to Q1, the odds of renal arterial calcification in Q4 was about two times higher (OR, 2.05; 95% CI, 1.29 to 3.25). After adjustment for renal arterial calcification and atherosclerotic risk factors, the only other vascular bed where perirenal fat thickness showed a significant association with calcification was the abdominal aorta (OR, 1.11; 95% CI, 1.00 to 1.23; P=0.045).

Conclusion

Perirenal fat thickness was independently associated with vascular calcification in the renal artery and abdominal aorta.

Citations

Citations to this article as recorded by  
  • Association between perirenal fat tissue thickness and subclinical atherosclerosis in patients newly diagnosed with type 2 diabetes: a cross-sectional study
    Işıl Isel, Mehmet Karagulle, Turgut Karabag
    Journal of Yeungnam Medical Science.2026; 43: 10.     CrossRef
  • The association of perirenal adipose tissue accumulation with left ventricular hypertrophy and the mediating role of insulin resistance: a cross-sectional study involving 1112 individuals with type 2 diabetes mellitus
    Wei Wang, Yang Chen, Xiu Ping Qiu, Xiu Li Guo
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Perirenal fat differs in patients with chronic kidney disease receiving different vitamin D-based treatments: a preliminary study
    Ana Checa-Ros, Antonella Locascio, Owahabanun-Joshua Okojie, Pablo Abellán-Galiana, Luis D’Marco
    BMC Nephrology.2025;[Epub]     CrossRef
  • Perirenal fat area is a preoperative predictor of hypertension resolution after laparoscopic sleeve gastrectomy: Generalized additive models
    Yue Li, Kai-Yuan Zheng, Zeng-Lin Liu, Tian-Ming Yu, Wen-Jie Zhang, Ming-Wei Zhong, San-Yuan Hu
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • The correlation of perirenal fat and atherosclerosis: A systematic review and meta-analysis
    Melika Golmohammadi, Parynaz Parhizgar, Farid Javandoust Gharehbagh, Legha Lotfollahi
    Science Progress.2025;[Epub]     CrossRef
  • Effect of viable and inactivated Lactobacillus rhamnosus GG administration on the prevention of diet-induced obesity in rats: Implication of white and brown adipose tissue and influence of bacterial viability
    Laura Arellano-García, María P. Portillo, J. Alfredo Martínez, Stéphanie Krisa, Iñaki Milton-Laskibar
    The Journal of Nutritional Biochemistry.2025; 144: 109982.     CrossRef
  • Perirenal adipose tissue accumulation mediates the adverse impact of the atherogenic index of plasma on lower extremity peripheral arterial disease
    Xiu Li Guo, Mei Tu, Xiu Ping Qiu, Wei Wang
    Scientific Reports.2025;[Epub]     CrossRef
  • A framework of biomarkers for adipose tissue aging: a consensus statement by the Aging Biomarker Consortium
    Jian Yu, Yankang Zhang, Ting Zhang, Yan Bi, Yan Chen, Zheng Chen, Zhe Dai, Feifan Guo, Lixin Guo, Cheng Hu, Xiangqing Kong, Jian Li, Pingsheng Liu, Yong Liu, Jing Qu, Qiqun Tang, Congyi Wang, Liheng Wang, Jiqiu Wang, Jianping Weng, Aimin Xu, Lingyan Xu, H
    Life Medicine.2025;[Epub]     CrossRef
  • Impact of Liver Transplantation on Adipose Tissue Compartments and Its Association With Metabolic Sequela
    Ramzi Hassouneh, Sean Flynn, Steve Shen, Michael Tseng, Anh Tuan Bui, Jay Pham, Dan Park, Scott Matherly, David Bruno, Seung Lee, Vinay Kumaran, Vaishali Patel, Mark Muthiah, Amit Sharma, Mohammad Shadab Siddiqui
    Transplantation.2024; 108(1): 235.     CrossRef
  • Perirenal fat thickness contributes to the estimated 10-year risk of cardiovascular disease and atherosclerotic cardiovascular disease in type 2 diabetes mellitus
    Wei Wang, Feng Yan Lv, Mei Tu, Xiu Li Guo
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Perirenal fat thickness is an independent predictor for metabolic syndrome in steatotic liver disease
    Jong Wook Choi, Chul-min Lee, Bo-Kyeong Kang, Mimi Kim
    Scientific Reports.2024;[Epub]     CrossRef
  • High perirenal fat thickness predicts a greater risk of recurrence in Chinese patients with unilateral nephrolithiasis
    Haichao Huang, Shi Chen, Wenzhao Zhang, Tao Wang, Peide Bai, Jinchun Xing, Huiqiang Wang, Bin Chen
    Renal Failure.2023;[Epub]     CrossRef
  • Development and validation of a preoperative nomogram for predicting the surgical difficulty of laparoscopic colectomy for right colon cancer: a retrospective analysis
    Ao Yu, Yuekai Li, Haifeng Zhang, Guanbo Hu, Yuetang Zhao, Jinghao Guo, Meng Wei, Wenbin Yu, Zhibo Yan
    International Journal of Surgery.2023; 109(4): 870.     CrossRef
  • Perirenal Adipose Tissue Is Associated With Renal Dysfunction and Abnormal Hemodynamics in Patients With HFpEF
    Eva M. Boorsma, Hidemi Sorimachi, Jozine M. ter Maaten, Dirk J. van Veldhuisen, Kazunori Omote, Naoki Takahashi, Jeffrey M. Testani, Tineke P. Willems, Adriaan A. Voors, Barry A. Borlaug
    JACC: Heart Failure.2023; 11(10): 1463.     CrossRef
  • Renal Compression in Heart Failure
    Eva M. Boorsma, Jozine M. ter Maaten, Adriaan A. Voors, Dirk J. van Veldhuisen
    JACC: Heart Failure.2022; 10(3): 175.     CrossRef
  • The perirenal fat thickness was independently associated with serum uric acid level in patients with type 2 diabetes mellitus
    Yuxian Yang, Yan Ma, Yanan Cheng, Yuechao Xu, Yuan Fang, Jing Ke, Dong Zhao
    BMC Endocrine Disorders.2022;[Epub]     CrossRef
  • Cardiorenal Fat: A Cardiovascular Risk Factor With Implications in Chronic Kidney Disease
    Luis D'Marco, María Jesús Puchades, Nayara Panizo, María Romero-Parra, Lorena Gandía, Elena Giménez-Civera, Elisa Pérez-Bernat, Miguel Gonzalez-Rico, José Luis Gorriz
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Anti-Obesity Effects of a Prunus persica and Nelumbo nucifera Mixture in Mice Fed a High-Fat Diet
    Jungbin Song, Jiye Kim, Hyo Jin Park, Hocheol Kim
    Nutrients.2020; 12(11): 3392.     CrossRef
Close layer
Review Articles
Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
Kelvin H. M. Kwok, Karen S. L. Lam
Endocrinol Metab. 2017;32(2):145-151.   Published online May 19, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.2.145
  • 8,896 View
  • 54 Download
  • 7 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   

Fibroblast growth factor 21 (FGF21) is an atypical member of the FGF family. Acting in an endocrine fashion, it increases glucose uptake, modulates lipid metabolism, and sensitizes insulin response in metabolically active organs, including the liver and adipose tissue. Emerging evidence shows a strong correlation between circulating FGF21 levels and the incidence and severity of atherosclerosis. Animal studies have demonstrated a beneficial role of FGF21 in protecting against aberrant lipid profile, while recent development in FGF21 mimetics has provided further insight into the lipid-lowering effects of FGF21 signaling. The present review summarizes the physiological roles of FGF21, and discusses major breakthroughs and limitations of FGF21 mimetic-based therapeutic strategies for treating atherosclerosis.

Citations

Citations to this article as recorded by  
  • Higher fasting fibroblast growth factor 21 was associated with a greater decline in postprandial blood pressure
    Jane Yu Ying Ong, Kaveri Pathak, Yun Zhao, Emily Calton, Christopher M. Reid, Mario J. Soares
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(2): 102720.     CrossRef
  • Potential role of fibroblast growth factor 21 in the deterioration of bone quality in impaired glucose tolerance
    D. T. W. Lui, C. H. Lee, V. W. K. Chau, C. H. Y. Fong, K. M. Y. Yeung, J. K. Y. Lam, A. C. H. Lee, W. S. Chow, K. C. B. Tan, Y. C. Woo, K. S. L. Lam
    Journal of Endocrinological Investigation.2021; 44(3): 523.     CrossRef
  • FGF21 induces autophagy‐mediated cholesterol efflux to inhibit atherogenesis via RACK1 up‐regulation
    Lin Xiaolong, Guo Dongmin, Mihua Liu, Wang Zuo, Hu Huijun, Tan Qiufen, Hu XueMei, Lin Wensheng, Pan Yuping, Lin Jun, Zeng Zhaolin
    Journal of Cellular and Molecular Medicine.2020; 24(9): 4992.     CrossRef
  • Two-hundred-liter scale fermentation, purification of recombinant human fibroblast growth factor-21, and its anti-diabetic effects on ob/ob mice
    Qi Hui, Zhen Huang, Shucai Pang, Xuanxin Yang, Jinghang Li, Bingjie Yu, Lu Tang, Xiaokun Li, Xiaojie Wang
    Applied Microbiology and Biotechnology.2019; 103(2): 719.     CrossRef
  • Protection Effect of Exogenous Fibroblast Growth Factor 21 on the Kidney Injury in Vascular Calcification Rats
    Yu-Chen Shi, Wei-Wei Lu, Yue-Long Hou, Kun Fu, Feng Gan, Shu-Juan Cheng, Shao-Ping Wang, Yong-Fen Qi, Jing-Hua Liu
    Chinese Medical Journal.2018; 131(5): 532.     CrossRef
Close layer
The Implication of Coronary Artery Calcium Testing for Cardiovascular Disease Prevention and Diabetes
Ron Blankstein, Ankur Gupta, Jamal S. Rana, Khurram Nasir
Endocrinol Metab. 2017;32(1):47-57.   Published online March 20, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.1.47
  • 11,028 View
  • 72 Download
  • 26 Web of Science
  • 25 Crossref
AbstractAbstract PDFPubReader   

Over the last two decades coronary artery calcium (CAC) scanning has emerged as a quick, safe, and inexpensive method to detect the presence of coronary atherosclerosis. Data from multiple studies has shown that compared to individuals who do not have any coronary calcifications, those with severe calcifications (i.e., CAC score >300) have a 10-fold increase in their risk of coronary heart disease events and cardiovascular disease. Conversely, those that have a CAC of 0 have a very low event rate (~0.1%/year), with data that now extends to 15 years in some studies. Thus, the most notable implication of identifying CAC in individuals who do not have known cardiovascular disease is that it allows targeting of more aggressive therapies to those who have the highest risk of having future events. Such identification of risk is especially important for individuals who are not on any therapies for coronary heart disease, or when intensification of treatment is being considered but has an uncertain role. This review will highlight some of the recent data on CAC testing, while focusing on the implications of those findings on patient management. The evolving role of CAC in patients with diabetes will also be highlighted.

Citations

Citations to this article as recorded by  
  • Risk profile and prognostic implications of premature advanced coronary atherosclerotic disease among young to early middle-aged adults: the coronary artery calcium consortium
    Ellen Boakye, Mohammadmoein Dehesh, Zeina Dardari, Olufunmilayo H Obisesan, Albert D Osei, Omar Dzaye, Kunal Jha, Alan Rozanski, Daniel S Berman, Matthew J Budoff, Michael D Miedema, Khurram Nasir, John A Rumberger, Leslee J Shaw, Michael J Blaha
    European Journal of Preventive Cardiology.2026; 33(9): 1621.     CrossRef
  • Development and validation of a novel nomogram to predict coronary artery calcification: a single center study
    Xiangnan Shen, Xia Li, Fang He, Honglei Su, Hongtao He, Guobin Kang
    European Journal of Medical Research.2025;[Epub]     CrossRef
  • Artificial Intelligence in Coronary Artery Calcium Scoring Detection and Quantification
    Khaled Abdelrahman, Arthur Shiyovich, Daniel Huck, Adam Berman, Brittany Weber, Sumit Gupta, Rhanderson Cardoso, Ron Blankstein
    Diagnostics.2024; 14(2): 125.     CrossRef
  • Association of Strict Versus Lenient Cholesterol Lowering with Cardiac Outcomes, Diabetes Progression and Complications, and Mortality in Patients with Diabetes Treated with Statins: Is Less More?
    Victoria Odeleye, Omar Masarweh, Jorge Restrepo, Carlos A Alvarez, Ishak A. Mansi
    Drug Safety.2023; 46(11): 1105.     CrossRef
  • Impact of coronary artery calcium testing on patient management
    Wanda Y. Wu, David W. Biery, Adam N. Berman, Grace Hsieh, Sanjay Divakaran, Sumit Gupta, Michael L. Steigner, Ayaz Aghayev, Hicham Skali, Donna M. Polk, Jorge Plutzky, Christopher P. Cannon, Marcelo F. Di Carli, Ron Blankstein
    Journal of Cardiovascular Computed Tomography.2022; 16(4): 303.     CrossRef
  • Application of ensemble machine learning algorithms on lifestyle factors and wearables for cardiovascular risk prediction
    Weiting Huang, Tan Wei Ying, Woon Loong Calvin Chin, Lohendran Baskaran, Ong Eng Hock Marcus, Khung Keong Yeo, Ng See Kiong
    Scientific Reports.2022;[Epub]     CrossRef
  • The Influence of Obesity and Metabolic Health on Vascular Health
    Eun-Jung Rhee
    Endocrinology and Metabolism.2022; 37(1): 1.     CrossRef
  • The role of cardiac computed tomography in predicting adverse coronary events
    Maria Emfietzoglou, Michail C. Mavrogiannis, Athanasios Samaras, Georgios P. Rampidis, George Giannakoulas, Polydoros N. Kampaktsis
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Subclinical Hypertension-Mediated Organ Damage (HMOD) in Hypertension: Atherosclerotic Cardiovascular Disease (ASCVD) and Calcium Score
    Damiano Rizzoni, Claudia Agabiti-Rosei, Carolina De Ciuceis, Gianluca Edoardo Mario Boari
    High Blood Pressure & Cardiovascular Prevention.2022; 30(1): 17.     CrossRef
  • Coronary Artery Calcium Score: Current Efficacy of Cardiac CT in Patients at Hail Region, Saudi Arabia
    Qurain Turki Alshammari, Ohood Alrashidi, Wed Almutairi, Eman Alshammari, Meshari T. Alshammari, Shashi Kumar CG, Mohammed Salih, Abdelmoneim Sulieman, Moawia Gameraddin, Bushra Abdul Malik, Amjad R. Alyahyawi
    International Journal of Pharmaceutical Research And Allied Sciences.2022; 11(3): 132.     CrossRef
  • The co-existence of diabetes and subclinical atherosclerosis in rural central Appalachia: Do residential characteristics matter?
    Hadii M. Mamudu, Antwan Jones, Timir K. Paul, Fenose Osedeme, David Stewart, Arsham Alamian, Liang Wang, Sylvester Orimaye, James Bledsoe, Amy Poole, Gerald Blackwell, Mathew Budoff
    Journal of Diabetes and its Complications.2021; 35(4): 107851.     CrossRef
  • Usefulness of skin advanced glycation end products to predict coronary artery calcium score in patients with type 2 diabetes
    Alejandra Planas, Olga Simó-Servat, Jordi Bañeras, Mónica Sánchez, Esther García, Ángel M. Ortiz, Marisol Ruiz-Meana, Cristina Hernández, Ignacio Ferreira-González, Rafael Simó
    Acta Diabetologica.2021; 58(10): 1403.     CrossRef
  • Value of addition of coronary artery calcium to risk scores in the prediction of major cardiovascular events in patients with type 2 diabetes
    Barak Zafrir, Walid Saliba, Rachel Shay Li Widder, Razi Khoury, Elad Shemesh, David A. Halon
    BMC Cardiovascular Disorders.2021;[Epub]     CrossRef
  • Coronary Artery Calcium Score - A Reliable Indicator of Coronary Artery Disease?
    Devarashetty Shreya, Diana I Zamora, Gautami S Patel, Idan Grossmann, Kevin Rodriguez, Mridul Soni, Pranay K Joshi, Saawan C Patel, Ibrahim Sange
    Cureus.2021;[Epub]     CrossRef
  • Metformin, resveratrol, and exendin-4 inhibit high phosphate-induced vascular calcification via AMPK-RANKL signaling
    Jinmi Lee, Seok-Woo Hong, Min-Jeong Kim, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
    Biochemical and Biophysical Research Communications.2020; 530(2): 374.     CrossRef
  • Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies
    Khaled M. Abdelrahman, Marcus Y. Chen, Amit K. Dey, Renu Virmani, Aloke V. Finn, Ramzi Y. Khamis, Andrew D. Choi, James K. Min, Michelle C. Williams, Andrew J. Buckler, Charles A. Taylor, Campbell Rogers, Habib Samady, Charalambos Antoniades, Leslee J. Sh
    Journal of the American College of Cardiology.2020; 76(10): 1226.     CrossRef
  • Optimizing coronary artery calcium scanning to meet the challenges of population screening
    Andrew J. Einstein
    Journal of Cardiovascular Computed Tomography.2019; 13(6): 303.     CrossRef
  • Usefulness of the Coronary Artery Calcium Score in Predicting Subsequent Coronary Interventions—A Ten-Year Single-Center Perspective
    Agnieszka Mlynarska, Rafal Mlynarski, Maciej Sosnowski
    International Journal of Environmental Research and Public Health.2019; 16(12): 2132.     CrossRef
  • Cardiovascular Risk Heterogeneity in Adults with Diabetes: Selective Use of Coronary Artery Calcium in Statin Use Decision-making
    Sudipa Sarkar, Olusola A. Orimoloye, Caitlin M. Nass, Roger S. Blumenthal, Seth S. Martin
    Journal of General Internal Medicine.2019; 34(11): 2643.     CrossRef
  • CT coronary imaging–a fast evolving world
    P Rajiah, S Abbara
    QJM: An International Journal of Medicine.2018; 111(9): 595.     CrossRef
  • Being Metabolically Healthy, the Most Responsible Factor for Vascular Health
    Eun-Jung Rhee
    Diabetes & Metabolism Journal.2018; 42(1): 19.     CrossRef
  • Diabetes, subclinical atherosclerosis and multiple cardiovascular risk factors in hard-to-reach asymptomatic patients
    Hadii M Mamudu, Arsham Alamian, Timir Paul, Pooja Subedi, Liang Wang, Antwan Jones, Ali E Alamin, David Stewart, Gerald Blackwell, Matthew Budoff
    Diabetes and Vascular Disease Research.2018; 15(6): 519.     CrossRef
  • Calcium detection, its quantification, and grayscale morphology-based risk stratification using machine learning in multimodality big data coronary and carotid scans: A review
    Sumit K. Banchhor, Narendra D. Londhe, Tadashi Araki, Luca Saba, Petia Radeva, Narendra N. Khanna, Jasjit S. Suri
    Computers in Biology and Medicine.2018; 101: 184.     CrossRef
  • Association Between Coronary Artery Calcification and the Hemoglobin Glycation Index: The Kangbuk Samsung Health Study
    Eun-Jung Rhee, Jung-Hwan Cho, Hyemi Kwon, Se Eun Park, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee
    The Journal of Clinical Endocrinology & Metabolism.2017; 102(12): 4634.     CrossRef
  • Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation
    Jihyun Kim, Da Young Lee, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee, Susanne Kaser
    PLOS ONE.2017; 12(7): e0180118.     CrossRef
Close layer
The Role of Macrophage Lipophagy in Reverse Cholesterol Transport
Se-Jin Jeong, Mi-Ni Lee, Goo Taeg Oh
Endocrinol Metab. 2017;32(1):41-46.   Published online March 20, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.1.41
  • 11,508 View
  • 113 Download
  • 48 Web of Science
  • 50 Crossref
AbstractAbstract PDFPubReader   

Macrophage cholesterol efflux is a central step in reverse cholesterol transport, which helps to maintain cholesterol homeostasis and to reduce atherosclerosis. Lipophagy has recently been identified as a new step in cholesterol ester hydrolysis that regulates cholesterol efflux, since it mobilizes cholesterol from lipid droplets of macrophages via autophagy and lysosomes. In this review, we briefly discuss recent advances regarding the mechanisms of the cholesterol efflux pathway in macrophage foam cells, and present lipophagy as a therapeutic target in the treatment of atherosclerosis.

Citations

Citations to this article as recorded by  
  • Lipid droplets beyond storage: Cellular metabolic modulator in the diabetic heart (Review)
    Yongchun Liang, Xinbiao Fan, Xiaofei Geng, Yunfeng Jia, Wenyu Shang, Xitong Sun, Jun Ge, Guijun Ye, Boyu Zhu, Zheng Zhang, Yuxin Kang, Xiaoyu Shan, Junping Zhang
    International Journal of Molecular Medicine.2026; 57(4): 1.     CrossRef
  • Expression of IMD-CBM peptide induces the autophagic degradation of CAV1 (caveolin 1) to inhibit LDL transcytosis and retard diabetic atherosclerosis
    Li Wang, Xiong Jia, Xiangli Bai, Ying Zhao, Wenzhuo Cheng, Meng Shu, Yan Shu, Liyin Zhang, Ruonan Wang, Si Jin
    Autophagy.2026; 22(6): 1273.     CrossRef
  • The role of selective autophagy in cardiovascular diseases: mechanisms and therapeutic potential
    Ting Zeng, Zhongjian Zhang, Chunliu Qian, Xiaoyu Li, Shuang Li
    The Journal of Cardiovascular Aging.2026;[Epub]     CrossRef
  • Hexosamine Biosynthetic Pathway and Fatty Acid β-Oxidative Imbalance: A Key Mechanism by Which Abnormal Macrophage Lipophagy Promotes Atherosclerosis in Diabetes
    Jin-ping Liu, Yu-hui Liu, Hao Luo, Yi-fei Wu, Shuai-yi Yu, Ya Wu, Yong Liu
    Cardiovascular Drugs and Therapy.2026;[Epub]     CrossRef
  • Phospholipid Transfer Protein (PLTP) in Cholesterol Handling: Implications for Mitochondrial Lipid Homeostasis in Human iPSC-Derived Cardiomyocytes
    Dhienda C. Shahannaz, Tadahisa Sugiura
    International Journal of Molecular Sciences.2026; 27(8): 3617.     CrossRef
  • Dual modulation of lipophagy: From molecular mechanisms to therapeutic interventions in cardiovascular health and disease
    Yunxia Wu, Weili Li, Heng Liu, Fei Ge, Guanjing Ling, Yawen Zhang, Yuqin Zhang, Yilin Li, Yan Wei, Shujuan Guo, Wei Wang, Yong Wang
    Pharmacological Research.2026; 228: 108204.     CrossRef
  • Fatty acid metabolism and lipid channeling in macrophages: mechanisms of inflammation, resolution, and lipotoxicity
    Temitayo T. Bamgbose, Oluwakemi O. Igiehon, Javier Nion-Fieira, Cora R. Palmer, Andrii Andriichuk, Matthew D. Woolard
    Frontiers in Immunology.2026;[Epub]     CrossRef
  • From lipid overload to autophagy collapse: how lipid dysregulation drives chronic inflammation and metabolic disease
    Mykyta Fomin, Konstantin Zapf, Elisabeth Schieffer, Johannes Freitag, Gert Bange, Bernhard Schieffer
    Inflammation Research.2026;[Epub]     CrossRef
  • Sex-specific transcriptional regulation in lung macrophages during sub-acute Mycobacterium tuberculosis infection
    Dhanya Dhanyalayam, Hariprasad Thangavel, Kezia Lizardo, Jigar V. Desai, Jyothi F. Nagajyothi, Prabagaran Narayanasamy
    Microbiology Spectrum.2025;[Epub]     CrossRef
  • Tianxiangdan suppresses foam cell formation by enhancing lipophagy and reduces the progression of atherosclerosis
    Ya-jie Zhang, Huan He, Guligena Sawuer, Xue-kuan Ma, Zulihumaer Ainiwaer, Dan-dan Wu, Xia-xia Zhang, Dong-qing An
    In Vitro Cellular & Developmental Biology - Animal.2025; 61(3): 298.     CrossRef
  • Cellular stress and macrophage activation
    Jing Yu, Bin-Zhi Qian
    Seminars in Immunology.2025; 78: 101953.     CrossRef
  • The converging roles of microRNAs and lipid metabolism in atherosclerotic cardiovascular disease and cancer
    Sandra Vladimirov, Marija Tomasevic, Nemanja Popov, Jelena Munjas, David de Gonzalo-Calvo, Miron Sopic
    Seminars in Cancer Biology.2025; 114: 41.     CrossRef
  • ApoA1-driven cholesterol efflux and macrophage polarization orchestrate T-cell differentiation towards controlling Leishmania donovani pathogenesis
    Vikash Kumar, Dayakar Alti, Shobha Kumari, Ravi Ranjan, Divya Prasad, Veer Singh, Abhik Sen, Pradeep Das, Krishna Pandey, Ashish Kumar
    Scientific Reports.2025;[Epub]     CrossRef
  • The mitochondrial translocator protein (TSPO, 18 kDa): A key multifunctional molecule in liver diseases
    Yuchang Li, Liting Chen, Vassilios Papadopoulos
    Biochimie.2024; 224: 91.     CrossRef
  • Bile salt signaling and bile salt-based therapies in cardiometabolic disease
    Claire C.J. Groenen, Thuc-Anh Nguyen, Coen C. Paulusma, Stan F.J. van de Graaf
    Clinical Science.2024; 138(1): 1.     CrossRef
  • Insights into the role of FGF21 in coronary heart disease
    Qin-Yao Zhang, Hui-Xin Liu
    International Journal of Biological Macromolecules.2024; 282: 136911.     CrossRef
  • Mechanistic insights into the regression of atherosclerotic plaques
    Jianshu Song, Ce Cao, Ziyan Wang, Haoran Li, Lili Yang, Jing Kang, Hongxu Meng, Lei Li, Jianxun Liu
    Frontiers in Physiology.2024;[Epub]     CrossRef
  • Huazhuotongmai decoction exerts anti-atherosclerotic effects by modulating the expression of ABCA1/SR-B1/PPAR-γ in vivo and in vitro
    Ya-ru Yan, Zi-jun Jia, Ya Wang, Feng-qin Xu, Qing-bing Zhou
    Phytomedicine Plus.2023; 3(2): 100436.     CrossRef
  • The SGLT2 Inhibitor Canagliflozin Reduces Atherosclerosis by Enhancing Macrophage Autophagy
    Hongping Chen, Da Teng, Bowen Xu, Chunxiao Wang, Hua Wang, Wenjuan Jia, Lei Gong, Haibin Dong, Lin Zhong, Jun Yang
    Journal of Cardiovascular Translational Research.2023; 16(5): 999.     CrossRef
  • FURIN suppresses the progression of atherosclerosis by promoting macrophage autophagy
    Hongping Chen, Lihui Zhang, Shaohua Mi, Hua Wang, Chunxiao Wang, Wenjuan Jia, Lei Gong, Haibin Dong, Bowen Xu, Yanyan Jing, Peipei Ge, Zhigang Pei, Lin Zhong, Jun Yang
    The FASEB Journal.2023;[Epub]     CrossRef
  • Unbalanced Redox With Autophagy in Cardiovascular Disease
    Se-Jin Jeong, Goo Taeg Oh
    Journal of Lipid and Atherosclerosis.2023; 12(2): 132.     CrossRef
  • Edible Bird’s Nest Effectively Attenuates Atherosclerosis through Modulation of Cholesterol Metabolism via Activation of PPARγ/LXRα Signaling Pathway In Vivo
    Nurul Nadiah Mohamad Nasir, Ramlah Mohamad Ibrahim, Rozi Mahmud, Nor Asma Ab Razak, Norsharina Ismail, Kim Wei Chan, Md Zuki Abu Bakar, Akhilesh K. Verma
    Journal of Food Biochemistry.2023; 2023: 1.     CrossRef
  • The Differential Metabolomes in Cumulus and Mural Granulosa Cells from Human Preovulatory Follicles
    Er-Meng Gao, Bongkoch Turathum, Ling Wang, Di Zhang, Yu-Bing Liu, Rong-Xin Tang, Ri-Cheng Chian
    Reproductive Sciences.2022; 29(4): 1343.     CrossRef
  • PHLPP1 promotes neutral lipid accumulation through AMPK/ChREBP-dependent lipid uptake and fatty acid synthesis pathways
    Keerthana Balamurugan, Raghavender Medishetti, Jyothi Kotha, Parameshwar Behera, Kanika Chandra, Vijay Aditya Mavuduru, Manjunath B. Joshi, Ramesh Samineni, Madhumohan R. Katika, Writoban Basu Ball, Manjunatha Thondamal, Anil Challa, Kiranam Chatti, Kisho
    iScience.2022; 25(2): 103766.     CrossRef
  • Hydrochloride Berberine ameliorates alcohol-induced liver injury by regulating inflammation and lipid metabolism
    Xiumei Ke, Ruoyu Zhang, Pan Li, Ling Zuo, Meng Wang, Junxuan Yang, Jianwei Wang
    Biochemical and Biophysical Research Communications.2022; 610: 49.     CrossRef
  • Metabolic Regulation of Macrophage Activation
    Ourania Kolliniati, Eleftheria Ieronymaki, Eleni Vergadi, Christos Tsatsanis
    Journal of Innate Immunity.2022; 14(1): 51.     CrossRef
  • Emerging Roles of Lipophagy in Cancer Metastasis
    Haimeng Yin, Ying Shan, Tian Xia, Yan Ji, Ling Yuan, Yiwen You, Bo You
    Cancers.2022; 14(18): 4526.     CrossRef
  • Genetic Factors for Coronary Heart Disease and Their Mechanisms: A Meta-Analysis and Comprehensive Review of Common Variants from Genome-Wide Association Studies
    Khairul Anwar Zarkasi, Noraidatulakma Abdullah, Nor Azian Abdul Murad, Norfazilah Ahmad, Rahman Jamal
    Diagnostics.2022; 12(10): 2561.     CrossRef
  • Caveolin-1 in autophagy: A potential therapeutic target in atherosclerosis
    Kai Hou, Shuai Li, Meng Zhang, Xuping Qin
    Clinica Chimica Acta.2021; 513: 25.     CrossRef
  • Contradictory regulation of macrophages on atherosclerosis based on polarization, death and autophagy
    Jing Zhang, Chuan-Rui Ma, Yun-Qing Hua, Lan Li, Jing-Yu Ni, Yu-Ting Huang, Sophia Esi Duncan, Sheng Li, Shan Gao, Guan-Wei Fan
    Life Sciences.2021; 276: 118957.     CrossRef
  • A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis
    Binbin Xie, Jiang He, Yong Liu, Ting Liu, Chaoqun Liu
    Lipids in Health and Disease.2021;[Epub]     CrossRef
  • Rosmarinic Acid Increases Macrophage Cholesterol Efflux through Regulation of ABCA1 and ABCG1 in Different Mechanisms
    Jean-Baptiste Nyandwi, Young Shin Ko, Hana Jin, Seung Pil Yun, Sang Won Park, Hye Jung Kim
    International Journal of Molecular Sciences.2021; 22(16): 8791.     CrossRef
  • FGF21 induces autophagy‐mediated cholesterol efflux to inhibit atherogenesis via RACK1 up‐regulation
    Lin Xiaolong, Guo Dongmin, Mihua Liu, Wang Zuo, Hu Huijun, Tan Qiufen, Hu XueMei, Lin Wensheng, Pan Yuping, Lin Jun, Zeng Zhaolin
    Journal of Cellular and Molecular Medicine.2020; 24(9): 4992.     CrossRef
  • Lipophagy in atherosclerosis
    Qing Liu, Yuan-Mei Wang, Hong-Feng Gu
    Clinica Chimica Acta.2020; 511: 208.     CrossRef
  • Lysosomotropic Features and Autophagy Modulators among Medical Drugs: Evaluation of Their Role in Pathologies
    Tatiana A. Korolenko, Thomas P. Johnston, Vaclav Vetvicka
    Molecules.2020; 25(21): 5052.     CrossRef
  • LncRNA MALAT1 Enhances ox-LDL-Induced Autophagy through the SIRT1/MAPK/NF-κB Pathway in Macrophages
    Jiaqi Yang, Xuze Lin , Liangshan Wang, Tienan Sun, Qi Zhao, Qian Ma, Yujie Zhou
    Current Vascular Pharmacology.2020; 18(6): 652.     CrossRef
  • Autophagy in chronic stress induced atherosclerosis
    Na Li, Ru-Xin Zhang, Xue-Jiao Xie, Hong-Feng Gu
    Clinica Chimica Acta.2020; 503: 70.     CrossRef
  • CTRP13 inhibits atherosclerosis via autophagy‐lysosome‐dependent degradation of CD36
    Cheng Wang, Wenjing Xu, Minglu Liang, Dan Huang, Kai Huang
    The FASEB Journal.2019; 33(2): 2290.     CrossRef
  • Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed‐forward loop between LXR and autophagy
    P. Saliba‐Gustafsson, M. Pedrelli, K. Gertow, O. Werngren, V. Janas, S. Pourteymour, D. Baldassarre, E. Tremoli, F. Veglia, R. Rauramaa, A.J. Smit, P. Giral, S. Kurl, M. Pirro, U. de Faire, S.E. Humphries, A. Hamsten, I. Gonçalves, M. Orho‐Melander, A. Fr
    Journal of Internal Medicine.2019; 286(6): 660.     CrossRef
  • PCSK9: A new participant in lipophagy in regulating atherosclerosis?
    Jun Xiao, Yi-Min Deng, Xiang-Rui Liu, Jian-Ping Cao, Min Zhou, Ya-Ling Tang, Wen-Hao Xiong, Zhi-Sheng Jiang, Zhi-Han Tang, Lu-Shan Liu
    Clinica Chimica Acta.2019; 495: 358.     CrossRef
  • Autophagy-Mediated Cholesterol Trafficking Controls Steroid Production
    Michael J. Texada, Alina Malita, Christian F. Christensen, Kathrine B. Dall, Nils J. Faergeman, Stanislav Nagy, Kenneth A. Halberg, Kim Rewitz
    Developmental Cell.2019; 48(5): 659.     CrossRef
  • Lipophagy in nonliver tissues and some related diseases: Pathogenic and therapeutic implications
    Kebing Zhou, Pingbo Yao, Jun He, Hong Zhao
    Journal of Cellular Physiology.2019; 234(6): 7938.     CrossRef
  • Autophagy differentially regulates macrophage lipid handling depending on the lipid substrate (oleic acid vs. acetylated-LDL) and inflammatory activation state
    Sapir Hadadi-Bechor, Yulia Haim, Tal Pecht, Roni Gat, Tanya Tarnovscki, Martin Gericke, Assaf Rudich
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2019; 1864(12): 158527.     CrossRef
  • Autophagy and Age-Related Eye Diseases
    Xue Yang, Xinan Pan, Xiaorui Zhao, Jin Luo, Mingpu Xu, Daoming Bai, Yan Hu, Xu Liu, Qiongfang Yu, Dian Gao
    BioMed Research International.2019; 2019: 1.     CrossRef
  • Foam cell formation and cholesterol trafficking and metabolism disturbances in atherosclerosis
    Alexandrina Volobueva, Dongwei Zhang, Andrey V. Grechko, Alexander N. Orekhov
    Cor et Vasa.2019; 61(1): 48.     CrossRef
  • Oxidative Stress, Lipid Peroxidation, and Loss of Hyaluronic Acid in the Human Vitreous Affected by Synchysis Scintillans
    Loredana Bergandi, Oleksii A Skorokhod, Rosalba La Grotta, Evelin Schwarzer, Raffaele Nuzzi
    Journal of Ophthalmology.2019; 2019: 1.     CrossRef
  • Programmed cell death protein 4 deficiency suppresses foam cell formation by activating autophagy in advanced glycation end‐product low‐density lipoprotein–induced macrophages
    Shan Li, Guangdong Gao, Fuyun Wu, Dan Liu, Hongyan Zhao, Jing Ke, Ying Liu, Fei Li, Jian Li, Zongyun Chen, Zhiming Tang, Lei Bai, Jinxuan Zhang, Wei Zheng, Xin Chen
    Journal of Cellular Biochemistry.2019; 120(5): 7689.     CrossRef
  • Mindin deficiency in macrophages protects against foam cell formation and atherosclerosis by targeting LXR-β
    Cheng Zhang, Juan-Juan Qin, Fu-Han Gong, Jing-Jing Tong, Wen-Lin Cheng, Haiping Wang, Yan Zhang, Xueyong Zhu, Zhi-Gang She, Hao Xia, Li-Hua Zhu
    Clinical Science.2018; 132(11): 1199.     CrossRef
  • LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice
    Jong-Gil Park, Se-Jin Jeong, Jinha Yu, Gyudong Kim, Lak Shin Jeong, Goo Taeg Oh
    BMB Reports.2018; 51(10): 520.     CrossRef
  • Intracellular and Plasma Membrane Events in Cholesterol Transport and Homeostasis
    Dmitry Y. Litvinov, Eugeny V. Savushkin, Alexander D. Dergunov
    Journal of Lipids.2018; 2018: 1.     CrossRef
Close layer
Diabetes, Obesity and Metabolism
High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
Alice Ossoli, Chiara Pavanello, Laura Calabresi
Endocrinol Metab. 2016;31(2):223-229.   Published online June 10, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.2.223
  • 15,912 View
  • 108 Download
  • 47 Web of Science
  • 43 Crossref
AbstractAbstract PDFPubReader   

Epidemiological data clearly show the existence of a strong inverse correlation between plasma high-density lipoprotein cholesterol (HDL-C) concentrations and the incidence of coronary heart disease. This relation is explained by a number of atheroprotective properties of HDL, first of all the ability to promote macrophage cholesterol transport. HDL are highly heterogeneous and are continuously remodeled in plasma thanks to the action of a number of proteins and enzymes. Among them, lecithin:cholesterol acyltransferase (LCAT) plays a crucial role, being the only enzyme able to esterify cholesterol within lipoproteins. LCAT is synthetized by the liver and it has been thought to play a major role in reverse cholesterol transport and in atheroprotection. However, data from animal studies, as well as human studies, have shown contradictory results. Increased LCAT concentrations are associated with increased HDL-C levels but not necessarily with atheroprotection. On the other side, decreased LCAT concentration and activity are associated with decreased HDL-C levels but not with increased atherosclerosis. These contradictory results confirm that HDL-C levels per se do not represent the functionality of the HDL system.

Citations

Citations to this article as recorded by  
  • Proteome Analysis of Nasolacrimal Duct Lavage Fluid in Patients with Primary Acquired Nasolacrimal Duct Obstruction
    Heejeong You, Wonseok Bang, Byeongsoo Kang, Seunghoon Back, Junyoung Park, Minjung Ju, Jong-Moon Park, Helen Lew
    International Journal of Molecular Sciences.2026; 27(6): 2616.     CrossRef
  • Physiologic Recovery After Smoking Cessation: A Systematic Review of Inflammatory and Cardiovascular Biomarker Changes
    Ahmad Mohammad, Uday Shree Akkala Shetty, Roland Asiwe, Hafiz H Zubair, Zaeem Ahmad, Aryan Raj, Daniel E Cook, Ahmad Sattar
    Cureus.2026;[Epub]     CrossRef
  • Integrating transcriptomics and metabolomics reveals the molecular landscape of sperm maturation driven by regional differentiation in the epididymis of Guizhou-Guiqian semi-fine wool sheep
    Xujie Li, Huihui Wang, Xiaodan Shi, Ling Pu, Haolin Chen, Taotao Li
    Genomics.2026; 118(5): 111288.     CrossRef
  • Lycopene Alleviates Lipid Dysregulation, Oxidative Stress, and Hypercholesterolemia in Obese Rats Subjected to a High‐Fat Diet
    Sana Noreen, Somia Shehzadi, Chukwuebuka Egbuna, Patrick Maduabuchi Aja
    Food Science & Nutrition.2025;[Epub]     CrossRef
  • High-Tyrosol/Hydroxytyrosol Extra Virgin Olive Oil Enhances Antioxidant Activity in Elderly Post-Myocardial Infarction Patients
    Mojgan Morvaridzadeh, Mehdi Alami, Nada Zoubdane, Hawa Sidibé, Hicham Berrougui, Tamàs Fülöp, Michel Nguyen, Abdelouahed Khalil
    Antioxidants.2025; 14(7): 867.     CrossRef
  • Effect of Dietary PUFAs and Antioxidants on Antioxidant and Anti-Inflammatory Functions of HDL in a Cohort of Women
    Gianmarco Mola, Raffaella Riccetti, Domenico Sergi, Alessandro Trentini, Valentina Rosta, Angelina Passaro, Juana M. Sanz, Carlo Cervellati
    Antioxidants.2025; 14(10): 1221.     CrossRef
  • Dietary chenodeoxycholic acid alleviates cottonseed oil-induced hepatic lipid deposition and inflammation in juvenile black seabream (Acanthopagrus schlegelii)
    Yixin Gu, Heng Wang, Yangguang Bao, Wenli Zhao, Tingting Zhu, Peng Sun, Qicun Zhou, Min Jin
    Aquaculture Reports.2025; 45: 103231.     CrossRef
  • Association between Mycoplasma pneumoniae infection, high‑density lipoprotein metabolism and cardiovascular health (Review)
    Tao Shen, Yanfang Li, Tingting Liu, Yunzhi Lian, Luke Kong
    Biomedical Reports.2024;[Epub]     CrossRef
  • Cholesterol transport and beyond: Illuminating the versatile functions of HDL apolipoproteins through structural insights and functional implications
    Aishwarya Sudam Bhale, Olivier Meilhac, Christian Lefebvre d'Hellencourt, Mookambeswaran A. Vijayalakshmi, Krishnan Venkataraman
    BioFactors.2024; 50(5): 922.     CrossRef
  • Phytochemicals profiling of Cassia fistula fruit extract and its effect on serum lipids and hematological parameters in high‐fat diet‐induced hyperlipidemic female rats
    Maryam Tariq, Nazir Ahmad, Mahr Un Nisa, Muhammad Abdul Rahim, Eliasse Zongo
    Food Science & Nutrition.2024; 12(8): 5776.     CrossRef
  • Lecithin-cholesterol acyltransferase and paraoxonase-1 levels in atherosclerotic cardiovascular disease patients in Nigeria
    Promise C. Nwaejigh, Maria O. Ebesunun, Oluwaseye M. Oladimeji
    African Journal of Laboratory Medicine.2024;[Epub]     CrossRef
  • Low LCAT activity is linked to acute decompensated heart failure and mortality in patients with CKD
    Julia T. Stadler, Thomas Bärnthaler, Andrea Borenich, Insa E. Emrich, Hansjörg Habisch, Alankrita Rani, Michael Holzer, Tobias Madl, Gunnar H. Heine, Gunther Marsche
    Journal of Lipid Research.2024; 65(9): 100624.     CrossRef
  • The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients
    Roxana Nartea, Brindusa Ilinca Mitoiu, Ioana Ghiorghiu
    Current Issues in Molecular Biology.2023; 45(4): 3146.     CrossRef
  • Mannose-Coated Reconstituted Lipoprotein Nanoparticles for the Targeting of Tumor-Associated Macrophages: Optimization, Characterization, and In Vitro Evaluation of Effectiveness
    Akpedje S. Dossou, Morgan E. Mantsch, Ammar Kapic, William L. Burnett, Nirupama Sabnis, Jeffery L. Coffer, Rance E. Berg, Rafal Fudala, Andras G. Lacko
    Pharmaceutics.2023; 15(6): 1685.     CrossRef
  • Abdominal obesity negatively influences key metrics of reverse cholesterol transport
    Jennifer Härdfeldt, Marica Cariello, Sara Simonelli, Alice Ossoli, Natasha Scialpi, Marilidia Piglionica, Emanuela Pasculli, Alessia Noia, Elsa Berardi, Patrizia Suppressa, Giuseppina Piazzolla, Carlo Sabbà, Laura Calabresi, Antonio Moschetta
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2022; 1867(2): 159087.     CrossRef
  • Effects of Lactobacillus paracasei N1115 on dyslipidaemia: A randomized controlled study
    Hua Jiang, Shengjie Tan, Ke Ning, Hao Li, Wenzhi Zhao, Ai Zhao, Hong Zhu, Shijie Wang, Peiyu Wang, Yumei Zhang
    Journal of Functional Foods.2022; 89: 104956.     CrossRef
  • LCAT- targeted therapies: Progress, failures and future
    Kaixu Yang, Junmin Wang, Hongjiao Xiang, Peilun Ding, Tao Wu, Guang Ji
    Biomedicine & Pharmacotherapy.2022; 147: 112677.     CrossRef
  • Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis
    Yanyan Wang, Hai Gao, Xinya Huang, Zhaoan Chen, Pengyu Kang, Yunyi Zhou, Danhua Qin, Wenli Zhang, Jianping Liu
    Carbohydrate Polymers.2022; 292: 119632.     CrossRef
  • Lipidomic Approaches to Study HDL Metabolism in Patients with Central Obesity Diagnosed with Metabolic Syndrome
    Gabriele Mocciaro, Simona D’Amore, Benjamin Jenkins, Richard Kay, Antonio Murgia, Luis Vicente Herrera-Marcos, Stefanie Neun, Alice P. Sowton, Zoe Hall, Susana Alejandra Palma-Duran, Giuseppe Palasciano, Frank Reimann, Andrew Murray, Patrizia Suppressa, C
    International Journal of Molecular Sciences.2022; 23(12): 6786.     CrossRef
  • rHDL modeling and the anchoring mechanism of LCAT activation
    Tommaso Laurenzi, Chiara Parravicini, Luca Palazzolo, Uliano Guerrini, Elisabetta Gianazza, Laura Calabresi, Ivano Eberini
    Journal of Lipid Research.2021; 62: 100006.     CrossRef
  • Vasculoprotective properties of plasma lipoproteins from brown bears (Ursus arctos)
    Matteo Pedrelli, Paolo Parini, Jonas Kindberg, Jon M. Arnemo, Ingemar Bjorkhem, Ulrika Aasa, Maria Westerståhl, Anna Walentinsson, Chiara Pavanello, Marta Turri, Laura Calabresi, Katariina Öörni, Gérman Camejo, Ole Fröbert, Eva Hurt-Camejo
    Journal of Lipid Research.2021; 62: 100065.     CrossRef
  • The Fate of Dietary Cholesterol in the Kissing Bug Rhodnius prolixus
    Petter F. Entringer, David Majerowicz, Katia C. Gondim
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • Excesive consumption of unsaturated fatty acids leads to oxidative and inflammatory instability in Wistar rats
    Jelica D. Grujić-Milanović, Zoran Z. Miloradović, Nevena D. Mihailović-Stanojević, Vojislav V. Banjac, Strahinja Vidosavljević, Milan S. Ivanov, Danijela J. Karanović, Una-Jovana V. Vajić, Djurdjica M. Jovović
    Biomedicine & Pharmacotherapy.2021; 139: 111691.     CrossRef
  • Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy
    Isabella Giacomini, Federico Gianfanti, Maria Andrea Desbats, Genny Orso, Massimiliano Berretta, Tommaso Prayer-Galetti, Eugenio Ragazzi, Veronica Cocetta
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis
    Marco Zuin, Carlo Cervellati, Alessandro Trentini, Angelina Passaro, Valentina Rosta, Francesca Zimetti, Giovanni Zuliani
    Diagnostics.2021; 11(6): 984.     CrossRef
  • Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus
    Christina Kohlmorgen, Stephen Gerfer, Kathrin Feldmann, Sören Twarock, Sonja Hartwig, Stefan Lehr, Meike Klier, Irena Krüger, Carolin Helten, Petra Keul, Sabine Kahl, Amin Polzin, Margitta Elvers, Ulrich Flögel, Malte Kelm, Bodo Levkau, Michael Roden, Jen
    Diabetologia.2021; 64(8): 1834.     CrossRef
  • Impact of Dietary Lipids on the Reverse Cholesterol Transport: What We Learned from Animal Studies
    Bianca Papotti, Joan Carles Escolà-Gil, Josep Julve, Francesco Potì, Ilaria Zanotti
    Nutrients.2021; 13(8): 2643.     CrossRef
  • Supramolecular copolymer modified statin-loaded discoidal rHDLs for atherosclerotic anti-inflammatory therapy by cholesterol efflux and M2 macrophage polarization
    Qiqi Zhang, Jianhua He, Fengfei Xu, Xinya Huang, Yanyan Wang, Wenli Zhang, Jianping Liu
    Biomaterials Science.2021; 9(18): 6153.     CrossRef
  • Association between Small Dense Low-Density Lipoproteins and High-Density Phospolipid Content in Patients with Coronary Artery Disease with or without Diabetes
    Hanene Aoua, Ymène Nkaies, Ali Ben Khalfallah, Mohsen Sakly, Ezzedine Aouani, Nebil Attia
    Laboratory Medicine.2020; 51(3): 271.     CrossRef
  • Biomechanical and biochemical investigation of erythrocytes in late stage human leptospirosis
    J.A.X. Silva, A.V.P. Albertini, C.S.M. Fonseca, D.C.N. Silva, V.C.O. Carvalho, V.L.M. Lima, A. Fontes, E.V.L. Costa, R.A. Nogueira
    Brazilian Journal of Medical and Biological Research.2020;[Epub]     CrossRef
  • Cardioprotective Properties of HDL: Structural and Functional Considerations
    Eleni Pappa, Moses S. Elisaf, Christina Kostara, Eleni Bairaktari, Vasilis K. Tsimihodimos
    Current Medicinal Chemistry.2020; 27(18): 2964.     CrossRef
  • Relationship between non–high-density lipoprotein cholesterol/apolipoprotein A-I and monocyte/high-density lipoprotein cholesterol ratio and coronary heart disease
    Ya Li, Shu Li, Yulin Ma, Jialing Li, Mingying Lin, Jing Wan
    Coronary Artery Disease.2020; 31(7): 623.     CrossRef
  • Lipid transfer to high‐density lipoproteins in coronary artery disease patients with and without previous cerebrovascular ischemic events
    Carlos J.D.G. Barbosa, Raul C. Maranhão, Renata S. Barreiros, Fatima R. Freitas, André Franci, Célia M.C. Strunz, Flávia B.B. Arantes, Thauany M. Tavoni, José A.F. Ramires, Roberto Kalil Filho, José C. Nicolau
    Clinical Cardiology.2019; 42(11): 1100.     CrossRef
  • Antibodies Against the C-Terminus of ApoA-1 Are Inversely Associated with Cholesterol Efflux Capacity and HDL Metabolism in Subjects with and without Type 2 Diabetes Mellitus
    Robin P. F. Dullaart, Sabrina Pagano, Frank G. Perton, Nicolas Vuilleumier
    International Journal of Molecular Sciences.2019; 20(3): 732.     CrossRef
  • The effect of chronic kidney disease on lipid metabolism
    Neris Dincer, Tuncay Dagel, Baris Afsar, Adrian Covic, Alberto Ortiz, Mehmet Kanbay
    International Urology and Nephrology.2019; 51(2): 265.     CrossRef
  • Biological Consequences of Dysfunctional HDL
    Angela Pirillo, Alberico Luigi Catapano, Giuseppe Danilo Norata
    Current Medicinal Chemistry.2019; 26(9): 1644.     CrossRef
  • Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease
    Karlijn J. Nass, Eline H. van den Berg, Eke G. Gruppen, Robin P. F. Dullaart
    European Journal of Clinical Investigation.2018;[Epub]     CrossRef
  • An integrated metabolomic strategy for the characterization of the effects of Chinese yam and its three active components on septic cardiomyopathy
    Ning Zhou, Meng-Nan Zeng, Kai Li, Yan-Yun Yang, Zhi-Yao Bai, Xiao-Ke Zheng, Wei-Sheng Feng
    Food & Function.2018; 9(9): 4989.     CrossRef
  • Effect of Rosuvastatin on Cholesterol Efflux Capacity and Endothelial Function in Type 2 Diabetes Mellitus and Dyslipidemia
    Kyong Yeun Jung, Kyoung Min Kim, Sun Kyoung Han, Han Mi Yun, Tae Jung Oh, Sung Hee Choi, Kyong Soo Park, Hak Chul Jang, Soo Lim
    Circulation Journal.2018; 82(5): 1387.     CrossRef
  • Association Between Serum LDL-C and ApoB and SYNTAX Score in Patients With Stable Coronary Artery Disease
    Taiwu Lin, Luzhao Wang, Jingbin Guo, Peng Liu, Liheng Chen, Mengqiu Wei, Gongxin Li
    Angiology.2018; 69(8): 724.     CrossRef
  • Influence of i.v. lipid emulsion on lipoprotein subclass in preterm infants
    Hiroki Suganuma, Naho Ikeda, Natsuki Ohkawa, Hiromichi Shoji, Toshiaki Shimizu
    Pediatrics International.2018; 60(9): 839.     CrossRef
  • The HDL cholesterol/apolipoprotein A-I ratio: an indicator of cardiovascular disease
    Eun-Jung Rhee, Christopher D. Byrne, Ki-Chul Sung
    Current Opinion in Endocrinology, Diabetes & Obesity.2017; 24(2): 148.     CrossRef
  • Moringa Leaves Prevent Hepatic Lipid Accumulation and Inflammation in Guinea Pigs by Reducing the Expression of Genes Involved in Lipid Metabolism
    Manal Almatrafi, Marcela Vergara-Jimenez, Ana Murillo, Gregory Norris, Christopher Blesso, Maria Fernandez
    International Journal of Molecular Sciences.2017; 18(7): 1330.     CrossRef
Close layer
Namgok Lecture 2015
Diabetes, Obesity and Metabolism
The Impact of Organokines on Insulin Resistance, Inflammation, and Atherosclerosis
Kyung Mook Choi
Endocrinol Metab. 2016;31(1):1-6.   Published online March 16, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.1.1
  • 10,589 View
  • 88 Download
  • 50 Web of Science
  • 51 Crossref
AbstractAbstract PDFPubReader   

Immoderate energy intake, a sedentary lifestyle, and aging have contributed to the increased prevalence of obesity, sarcopenia, metabolic syndrome, type 2 diabetes, and cardiovascular disease. There is an urgent need for the development of novel pharmacological interventions that can target excessive fat accumulation and decreased muscle mass and/or strength. Adipokines, bioactive molecules derived from adipose tissue, are involved in the regulation of appetite and satiety, inflammation, energy expenditure, insulin resistance and secretion, glucose and lipid metabolism, and atherosclerosis. Recently, there is emerging evidence that skeletal muscle and the liver also function as endocrine organs that secrete myokines and hepatokines, respectively. Novel discoveries and research into these organokines (adipokines, myokines, and hepatokines) may lead to the development of promising biomarkers and therapeutics for cardiometabolic disease. In this review, I summarize recent data on these organokines and focus on the role of adipokines, myokines, and hepatokines in the regulation of insulin resistance, inflammation, and atherosclerosis.

Citations

Citations to this article as recorded by  
  • Meteorin-like protein inhibits vascular smooth muscle cell-derived foam cell formation and atherosclerosis via KIT- endoplasmic reticulum stress signaling
    Xu Chen, Xueying Jiang, Siyu Hou, Fengling Lai, Keqing Hu, Jie Li, Ting Yang, Xinxin Shen, Huimin Chen, Shen Chen, Xianfei Guo, Yan Zheng, Tao Xu, Guohai Su, Rong Huang
    Metabolism.2026; 176: 156459.     CrossRef
  • Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
    Zara Siu Wa Chui, Yaqian Xue, Xiaoping Wu, Aimin Xu
    Pharmacological Reviews.2026; : 100150.     CrossRef
  • Obesity-induced intervertebral disk degeneration: pathophysiology and clinical implications
    Prahalad Singh Bharti, Priya Kumari Gorai, Harshit Dutt, Yashdeep Gupta, Garima Malik, Neerja Rani, Vivek Shankar
    International Journal of Obesity.2026;[Epub]     CrossRef
  • Effects of stopped and reduced training on irisin and metabolic parameters in professional female basketball players
    Azam Heidari, Akram Jafari
    German Journal of Exercise and Sport Research.2025; 55(2): 202.     CrossRef
  • MAFLD as a Cardiovascular Risk Factor: An Extended Retrospective Study with a Control Group
    Małgorzata Szymala-Pędzik, Marcin Piersiak, Maciej Pachana, Karolina Lindner-Pawłowicz, Wioletta Szczepaniak, Małgorzata Sobieszczańska
    Journal of Clinical Medicine.2025; 14(12): 4181.     CrossRef
  • Research Progress on the Association Between Sarcopenic Obesity and Atherosclerosis: Current Status and Challenges
    Kai Yang, Wei Yang, Si-Cong Si, Jia Liu, Yi-Xin Ma, Huan Zhao
    Journal of Clinical Medicine.2025; 14(22): 8148.     CrossRef
  • Metabolic crossroads in insulin resistance: exploring lipid dysregulation and inflammation
    Saeede Saadati, Rasoul Godini, Anjana Reddy, Helena Teede, Aya Mousa
    Frontiers in Immunology.2025;[Epub]     CrossRef
  • Cardiometabolic diseases and early cognitive decline: Mitigated by integrated active lifestyle for brain health
    Haowei Li, Shige Qi, Shengshu Wang, Shanshan Yang, Shaohua Liu, Shimin Chen, Xuehang Li, Rongrong Li, Junhan Yang, Huaihao Li, Yinghui Bao, Yueting Shi, Zhihui Wang, Miao Liu, Yao He
    Journal of Affective Disorders.2024; 350: 155.     CrossRef
  • Current status and future perspectives of FGF21 analogues in clinical trials
    Zara Siu Wa Chui, Qing Shen, Aimin Xu
    Trends in Endocrinology & Metabolism.2024; 35(5): 371.     CrossRef
  • Organokinler ve Biyokimyasal Etkileri
    Ahmet İlhan, Umut Kökbaş
    Arşiv Kaynak Tarama Dergisi.2024; 33(1): 71.     CrossRef
  • The Significance of Selected Myokines in Predicting the Length of Rehabilitation of Patients after COVID-19 Infection
    Alicja Mińko, Agnieszka Turoń-Skrzypińska, Aleksandra Rył, Katarzyna Mańkowska, Aneta Cymbaluk-Płoska, Iwona Rotter
    Biomedicines.2024; 12(4): 836.     CrossRef
  • Hepatokines: unveiling the molecular and cellular mechanisms connecting hepatic tissue to insulin resistance and inflammation
    Xiaolei Miao, Arian Alidadipour, Vian Saed, Firooze Sayyadi, Yasaman Jadidi, Maryam Davoudi, Fatemeh Amraee, Nastaran Jadidi, Reza Afrisham
    Acta Diabetologica.2024; 61(11): 1339.     CrossRef
  • РОЛЬ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ В РАЗВИТИИ КАРДИОВАСКУЛЯРНЫХ ОСЛОЖНЕНИЙ ПРИ АБДОМИНАЛЬНОМ ОЖИРЕНИИ У ДЕТЕЙ (литературный обзор)
    Эльнара Ибрагимова , Лиля Гарифулина
    Международный журнал научной педиатрии.2024; 3(8): 710.     CrossRef
  • Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk
    Jose Marcos Sanches, Li Na Zhao, Albert Salehi, Claes B. Wollheim, Philipp Kaldis
    The FEBS Journal.2023; 290(3): 620.     CrossRef
  • Research Progress on the Mechanism of Obesity-Induced Cardiovascular Disease
    文清 刘
    Advances in Clinical Medicine.2023; 13(08): 12887.     CrossRef
  • The Pan-liver Network Theory
    Yaxing Zhang, Xian-Ming Fang
    Chinese Journal of Physiology.2023; 66(6): 401.     CrossRef
  • Higher serum level of CTRP15 in patients with coronary artery disease is associated with disease severity, body mass index and insulin resistance
    Abolfazl Shokoohi Nahrkhalaji, Reza Ahmadi, Reza Fadaei, Ghodratollah Panahi, Malihe Razzaghi, Soudabeh Fallah
    Archives of Physiology and Biochemistry.2022; 128(1): 276.     CrossRef
  • Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future
    João Paulo Margiotti dos Santos, Mariana Canevari de Maio, Monike Alves Lemes, Lucas Fornari Laurindo, Jesselina Francisco dos Santos Haber, Marcelo Dib Bechara, Pedro Sidnei do Prado, Eduardo Costa Rauen, Fernando Costa, Barbara Cristina de Abreu Pereira
    International Journal of Molecular Sciences.2022; 23(1): 498.     CrossRef
  • Hepatic PTEN Signaling Regulates Systemic Metabolic Homeostasis through Hepatokines-Mediated Liver-to-Peripheral Organs Crosstalk
    Flavien Berthou, Cyril Sobolewski, Daniel Abegg, Margot Fournier, Christine Maeder, Dobrochna Dolicka, Marta Correia de Sousa, Alexander Adibekian, Michelangelo Foti
    International Journal of Molecular Sciences.2022; 23(7): 3959.     CrossRef
  • Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Women: Effects of Lifestyle Modifications
    Maria Teresa Guagnano, Damiano D'Ardes, Rossi Ilaria, Francesca Santilli, Cosima Schiavone, Marco Bucci, Francesco Cipollone
    Journal of Clinical Medicine.2022; 11(10): 2759.     CrossRef
  • Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
    Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali, Archana Burman
    Journal of Cellular Biochemistry.2022; 123(10): 1553.     CrossRef
  • Organokines, Sarcopenia, and Metabolic Repercussions: The Vicious Cycle and the Interplay with Exercise
    Giulia Minniti, Letícia Maria Pescinini-Salzedas, Guilherme Almeida dos Santos Minniti, Lucas Fornari Laurindo, Sandra Maria Barbalho, Renata Vargas Sinatora, Lance Alan Sloan, Rafael Santos de Argollo Haber, Adriano Cressoni Araújo, Karina Quesada, Jesse
    International Journal of Molecular Sciences.2022; 23(21): 13452.     CrossRef
  • CURRENT CONCEPTS ON LEPTIN-MEDIATED REGULATION OF METABOLISM
    R. B. Aliiev
    Bulletin of Problems Biology and Medicine.2022; 1(4): 9-1.     CrossRef
  • Inflammatory biomarkers and prediction of insulin resistance in Congolese adults
    Reine Freudlendrich Eboka-Loumingou Sakou, Benjamin Longo-Mbenza, Mûnka Nkalla-Lambi, Etienne Mokondjimobe, Henry Germain Monabeka, Donatien Moukassa, Ange Antoine Abena, Mia Pamela Mekieje Tumchou, Venant Tchokonte-Nana
    Heliyon.2021; 7(2): e06139.     CrossRef
  • Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
    Ana Rita de Oliveira dos Santos, Bárbara de Oliveira Zanuso, Vitor Fernando Bordin Miola, Sandra Maria Barbalho, Patrícia C. Santos Bueno, Uri Adrian Prync Flato, Claudia Rucco P. Detregiachi, Daniela Vieira Buchaim, Rogério Leone Buchaim, Ricardo José To
    International Journal of Molecular Sciences.2021; 22(5): 2639.     CrossRef
  • The Effects of Two Different Intensities of Combined Training on C1q/TNF-Related Protein 3 (CTRP3) and Insulin Resistance in Women with Non-alcoholic Fatty Liver Disease
    Somayeh Rajabi, Roya Askari, Amir Hossein Haghighi, Nasrin Razavianzadeh
    Hepatitis Monthly.2021;[Epub]     CrossRef
  • Handgrip and sex-specific cardiometabolic risk factors in Hispanic/Latino migrant farmworkers
    Anas Raed, Jessica Bilz, Miriam Cortez-Cooper, Lufei Young, Li Chen, Pamela Cromer, Haidong Zhu, Andrew Mazzoli, Samip Parikh, Jigar Bhagatwala, Yutong Dong, Zhuo Sun, Debbie Layman, Yanbin Dong
    Scientific Reports.2021;[Epub]     CrossRef
  • Crossing the Antarctica: Exploring the Effects of Appetite-Regulating Hormones and Indicators of Nutrition Status during a 93-Day Solo-Expedition
    Bjørn Helge Johnsen, Guttorm Brattebø, Terry M. Phillips, Rune Gjeldnes, Paul T. Bartone, Hans-Olav Neteland Monsen, Julian F. Thayer
    Nutrients.2021; 13(6): 1777.     CrossRef
  • Irisin in atherosclerosis
    Zhe-Bin Cheng, Liang Huang, Xuan Xiao, Jia-Xiang Sun, Zi-Kai Zou, Jie-Feng Jiang, Cong Lu, Hai-Ya Zhang, Chi Zhang
    Clinica Chimica Acta.2021; 522: 158.     CrossRef
  • Pilates and TRX training methods can improve insulin resistance in overweight women by increasing an exercise-hormone, Irisin
    Marzyeh Rahimi, Parvaneh Nazarali, Rostam Alizadeh
    Journal of Diabetes & Metabolic Disorders.2021; 20(2): 1455.     CrossRef
  • Effects of GLP-1 receptor agonists on myokine levels and pro-inflammatory cytokines in patients with type 2 diabetes mellitus
    Valentina Guarnotta, Maria J. Bianco, Enrica Vigneri, Felicia Panto’, Bruna Lo Sasso, Marcello Ciaccio, Giuseppe Pizzolanti, Carla Giordano
    Nutrition, Metabolism and Cardiovascular Diseases.2021; 31(11): 3193.     CrossRef
  • Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
    Tae Hyun Kim, Dong-Gyun Hong, Yoon Mee Yang
    Biomedicines.2021; 9(12): 1903.     CrossRef
  • Higher circulating levels of ANGPTL8 are associated with body mass index, triglycerides, and endothelial dysfunction in patients with coronary artery disease
    Reza Fadaei, Hossein Shateri, Johanna K. DiStefano, Nariman Moradi, Mohammad Mohammadi, Farzad Emami, Hassan Aghajani, Nasrin Ziamajidi
    Molecular and Cellular Biochemistry.2020; 469(1-2): 29.     CrossRef
  • Nonalcoholic fatty liver disease and cardiovascular disease phenotypes
    Giandomenico Bisaccia, Fabrizio Ricci, Cesare Mantini, Claudio Tana, Gian Luca Romani, Cosima Schiavone, Sabina Gallina
    SAGE Open Medicine.2020;[Epub]     CrossRef
  • Dysregulated Autophagy Mediates Sarcopenic Obesity and Its Complications via AMPK and PGC1α Signaling Pathways: Potential Involvement of Gut Dysbiosis as a Pathological Link
    Ji Yeon Ryu, Hyung Muk Choi, Hyung-In Yang, Kyoung Soo Kim
    International Journal of Molecular Sciences.2020; 21(18): 6887.     CrossRef
  • Fetuin-A as a Potential Biomarker of Metabolic Variability Following 60 Days of Bed Rest
    Kiera Ward, Edwin Mulder, Petra Frings-Meuthen, Donal J. O’Gorman, Diane Cooper
    Frontiers in Physiology.2020;[Epub]     CrossRef
  • Effect of Moderate Aerobic Exercise on Serum Levels of FGF21 and Fetuin A in Women with Type 2 Diabetes
    Exir Vizvari, Parvin farzanegi, Hajar Abbas Zade
    Medical Laboratory Journal.2020; 14(6): 17.     CrossRef
  • The implication of hepatokines in metabolic syndrome
    Maryam Esfahani, Mostafa Baranchi, Mohammad Taghi Goodarzi
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(4): 2477.     CrossRef
  • The Role of Adipose Tissue and Adipokines in Sepsis: Inflammatory and Metabolic Considerations, and the Obesity Paradox
    Irene Karampela, Gerasimos Socrates Christodoulatos, Maria Dalamaga
    Current Obesity Reports.2019; 8(4): 434.     CrossRef
  • Sarcopenia and myokines profile as risk factors in cardiovascular diseases?
    Mariusz Ciołkiewicz, Anna Kuryliszyn-Moskal, Anna Hryniewicz, Karol Kamiński
    Postępy Higieny i Medycyny Doświadczalnej.2019; 73: 550.     CrossRef
  • Pathophysiological Implication of Fetuin-A Glycoprotein in the Development of Metabolic Disorders: A Concise Review
    Lynda Bourebaba, Krzysztof Marycz
    Journal of Clinical Medicine.2019; 8(12): 2033.     CrossRef
  • Loss of Glycine N-Methyltransferase Associates with Angiopoietin-Like Protein 8 Expression in High Fat-Diet-Fed Mice
    Jian-Wei Huang, Chao-Ju Chen, Chia-Hung Yen, Yi-Ming Arthur Chen, Yu-Peng Liu
    International Journal of Molecular Sciences.2019; 20(17): 4223.     CrossRef
  • Recent advances in biosensor technology in assessment of early diabetes biomarkers
    Armin Salek-Maghsoudi, Faezeh Vakhshiteh, Raheleh Torabi, Shokoufeh Hassani, Mohammad Reza Ganjali, Parviz Norouzi, Morteza Hosseini, Mohammad Abdollahi
    Biosensors and Bioelectronics.2018; 99: 122.     CrossRef
  • Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study
    Miikka-Juhani Honka, Aino Latva-Rasku, Marco Bucci, Kirsi A Virtanen, Jarna C Hannukainen, Kari K Kalliokoski, Pirjo Nuutila
    European Journal of Endocrinology.2018; 178(5): 523.     CrossRef
  • Magnetic multiwalled carbon nanotubes as nanocarrier tags for sensitive determination of fetuin in saliva
    Esther Sánchez-Tirado, Araceli González-Cortés, Paloma Yáñez-Sedeño, José M. Pingarrón
    Biosensors and Bioelectronics.2018; 113: 88.     CrossRef
  • Decreased muscle mass in Korean subjects with intracranial arterial stenosis: The Kangbuk Samsung Health Study
    Ho-Jung Jung, Hwanseok Jung, Taeyoung Lee, Jongho Kim, Jongsin Park, Hacsoo Kim, Junghwan Cho, Won-Young Lee, Sung-Woo Park, Eun-Jung Rhee, Hyung-Geun Oh
    Atherosclerosis.2017; 256: 89.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
  • Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES
    Jang Won Son, Seong Su Lee, Sung Rae Kim, Soon Jib Yoo, Bong Yun Cha, Ho Young Son, Nam H. Cho
    Diabetologia.2017; 60(5): 865.     CrossRef
  • Effects of chlorogenic acid on intracellular calcium regulation in lysophosphatidylcholine-treated endothelial cells
    Hye-Jin Jung, Seung-Soon Im, Dae-Kyu Song, Jae-Hoon Bae
    BMB Reports.2017; 50(6): 323.     CrossRef
  • Irisin: A Potential Link between Physical Exercise and Metabolism—An Observational Study in Differently Trained Subjects, from Elite Athletes to Sedentary People
    Stefano Benedini, Elena Dozio, Pietro Luigi Invernizzi, Elena Vianello, Giuseppe Banfi, Ileana Terruzzi, Livio Luzi, Massimiliano Marco Corsi Romanelli
    Journal of Diabetes Research.2017; 2017: 1.     CrossRef
  • Serum Vaspin Concentration in Elderly Type 2 Diabetes Mellitus Patients with Differing Body Mass Index: A Cross-Sectional Study
    Wei Yang, Yun Li, Tian Tian, Li Wang
    BioMed Research International.2017; 2017: 1.     CrossRef
Close layer
Original Article
Clinical Study
Subclinical Atherosclerosis in Patients with Cushing Syndrome: Evaluation with Carotid Intima-Media Thickness and Ankle-Brachial Index
Luigi Petramala, D'Elia Lorenzo, Gino Iannucci, Antonio Concistré, Laura Zinnamosca, Cristiano Marinelli, Giuseppe De Vincentis, Antonio Ciardi, Giorgio De Toma, Claudio Letizia
Endocrinol Metab. 2015;30(4):488-493.   Published online December 31, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.4.488
  • 7,668 View
  • 46 Download
  • 8 Web of Science
  • 9 Crossref
AbstractAbstract PDFPubReader   
Background

Cushing syndrome (CS) has been described as a killing disease due its cardiovascular complications. In fact, chronic cortisol excess leads to a constellation of complications, including hypertension, hyperglycemia, adiposity, and thromboembolism. The main vascular alteration associated with CS is atherosclerosis.

Methods

Aim of this study was to analyze carotid intima-media thickness (cIMT) and ankle-brachial index (ABI), two surrogate markers of subclinical atherosclerosis in a consecutive series of CS patients, compared to patients with essential hypertension (EH) and health subjects (HS).

Results

Patients with CS showed a significant increase (P<0.05) of cIMT (0.89±0.17 mm) compared to EH (0.81±0.16 mm) and HS (0.75±0.4 mm), with a high prevalence of plaque (23%; P<0.03). Moreover, CS patients showed a mean ABI values (1.07±0.02) significantly lower respect to HS (1.12±0.11; P<0.05), and a higher percentage (20%) of pathological values of ABI (≤0.9; P<0.03).

Conclusion

In conclusion, we confirmed and extended the data of cIMT in CS, and showed that the ABI represent another surrogate marker of subclinical atherosclerosis in this disease.

Citations

Citations to this article as recorded by  
  • Prevalence of Hypercortisolism in Hypertension and Its Link to Carotid Atherosclerosis Markers
    Antonio Musolino, Chiara Parazzoli, Elisa Delle Donne, Vittoria Favero, Carmen Aresta, Grzegorz Bilo, Alessandro Croce, Martino Pengo, Gianfranco Parati, Luca Persani, Alfredo Scillitani, Iacopo Chiodini, Valentina Morelli
    Endocrine Practice.2026; 32(3): 329.     CrossRef
  • Endocrine Disorders and Peripheral Arterial Disease – A Series of Reviews Cushing Syndrome-Cortisol Excess
    Poredoš P, Schernthaner GH, Blinc A, Mikhailidis DP, Jensterle M, Anagnostis P, Antignani PL, Bajuk Studen K, Šabović M, Ježovnik MK
    Current Vascular Pharmacology.2024; 22(4): 236.     CrossRef
  • Micro- and Macrovascular Effects of Inflammation in Peripheral Artery Disease—Pathophysiology and Translational Therapeutic Approaches
    Michael Poledniczek, Christoph Neumayer, Christoph W. Kopp, Oliver Schlager, Thomas Gremmel, Alicja Jozkowicz, Michael E. Gschwandtner, Renate Koppensteiner, Patricia P. Wadowski
    Biomedicines.2023; 11(8): 2284.     CrossRef
  • Capillary microarchitectural changes in Cushing's syndrome
    Tugce Apaydin, Yasemin Yalcinkaya, Can Ilgin, Dilek Gogas Yavuz
    Microvascular Research.2022; 141: 104323.     CrossRef
  • Glucocorticoid therapy is a risk factor for cardiovascular diseases
    I. S. Dzherieva, N. I. Volkova, I. Y. Davidenko, I. B. Reshetnikov, S. S. Brovkina, S. M. Avakova, Y. V. Tishchenko
    Medical Herald of the South of Russia.2022; 13(3): 93.     CrossRef
  • Glucocorticoids: Fuelling the Fire of Atherosclerosis or Therapeutic Extinguishers?
    Clare MacLeod, Patrick W. F. Hadoke, Mark Nixon
    International Journal of Molecular Sciences.2021; 22(14): 7622.     CrossRef
  • Cardiovascular and metabolic risk factors in patients with subclinical Cushing
    Luigi Petramala, Federica Olmati, Antonio Concistrè, Riccardo Russo, Martina Mezzadri, Maurizio Soldini, Giuseppe De Vincentis, Gino Iannucci, Giorgio De Toma, Claudio Letizia
    Endocrine.2020; 70(1): 150.     CrossRef
  • Should Cushing's Syndrome be Considered as a Disease with High Cardiovascular Risk in Relevant Guidelines?
    Goran Koracevic, Milan Stojkovic, Dragan Lovic, Milan Pavlovic, Tomislav Kostic, Marija Kutlesic, Sladjana Micic, Maja Koracevic, Milan Djordjevic
    Current Vascular Pharmacology.2019; 18(1): 12.     CrossRef
  • Markers of atherosclerosis in patients with Cushing’s syndrome: a meta-analysis of literature studies
    Roberta Lupoli, Pasquale Ambrosino, Anna Tortora, Livia Barba, Gelsy Arianna Lupoli, Matteo Nicola Dario Di Minno
    Annals of Medicine.2017; 49(3): 206.     CrossRef
Close layer
Review Article
Diabetes, Obesity and Metabolism
High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
Philip J. Barter
Endocrinol Metab. 2013;28(3):169-177.   Published online September 13, 2013
DOI: https://doi.org/10.3803/EnM.2013.28.3.169
  • 8,567 View
  • 42 Download
  • 29 Crossref
AbstractAbstract PDFPubReader   

High density lipoproteins (HDLs) have a number of properties that have the potential to inhibit the development of atherosclerosis and thus reduce the risk of having a cardiovascular event. These protective effects of HDLs may be reduced in patients with type 2 diabetes, a condition in which the concentration of HDL cholesterol is frequently low. In addition to their potential cardioprotective properties, HDLs also increase the uptake of glucose by skeletal muscle and stimulate the synthesis and secretion of insulin from pancreatic β cells and may thus have a beneficial effect on glycemic control. This raises the possibility that a low HDL concentration in type 2 diabetes may contribute to a worsening of diabetic control. Thus, there is a double case for targeting HDLs in patients with type 2 diabetes: to reduce cardiovascular risk and also to improve glycemic control. Approaches to raising HDL levels include lifestyle factors such as weight reduction, increased physical activity and stopping smoking. There is an ongoing search for HDL-raising drugs as agents to use in patients with type 2 diabetes in whom the HDL level remains low despite lifestyle interventions.

Citations

Citations to this article as recorded by  
  • Association Between Neutrophil‐To‐HDL Cholesterol Ratio and Insulin Resistance in Individuals With Obesity: Cross‐Sectional Study of Chinese and U.S. Cohorts
    Zhenguang Mo, Yuzhou Yang, Zhenpeng Wu, Bingsheng Guan, Lvjia Cheng, Wenfu Ding, Lina Wu, Shifang Huang, Jian Xie, Jingge Yang
    Lipids.2026; 61(4): 493.     CrossRef
  • Relationship between asprosin and certain biochemical parameters in obese patients
    N. S. Humadi, N. A. Saleh
    Regulatory Mechanisms in Biosystems.2025; 16(2): e25059.     CrossRef
  • Role of Circulating Lipids in Mediating the Diabetogenic Effect of Obesity
    Yutang Wang, Yan Fang, Fadi J. Charchar, Grant R. Drummond, Christopher G. Sobey
    Biomedicines.2025; 14(1): 11.     CrossRef
  • Association between high-density lipoprotein cholesterol and type 2 diabetes mellitus: dual evidence from NHANES database and Mendelian randomization analysis
    Zhaoqi Yan, Yifeng Xu, Keke Li, Liangji Liu
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • HDL-C criterion of the metabolic syndrome and future diabetes and atherosclerosis in midlife women: The SWAN Study
    Ziyuan Wang, Emma Barinas-Mitchell, Maria M. Brooks, Sybil L. Crawford, Aleda M. Leis, Carol A. Derby, Rebecca C. Thurston, Monique M. Hedderson, Imke Janssen, Elizabeth A. Jackson, Daniel S. McConnell, Samar R. El Khoudary
    American Journal of Preventive Cardiology.2024; 19: 100687.     CrossRef
  • Correlation of serum HDL level with HRV indices using multiple linear regression analysis in patients with type 2 diabetes mellitus
    Fareedabanu A. Balikai, Shivalingappa B. Javali, Varsha M. Shindhe, Neeta Deshpande, Jyoti M. Benni, Darshit P. Shetty, Nitin Kapoor, Kamaruddin Jaalam
    Diabetes Research and Clinical Practice.2022; 190: 109988.     CrossRef
  • High Vaccenic Acid Content in Beef Fat Attenuates High Fat and High Carbohydrate Western Diet Induced Changes in Lipid Metabolism and Gut Microbiota in Pigs
    Vijay P. Singh, Melanie A. Fontaine, Rabban Mangat, Janelle M. Fouhse, Abdoulaye Diane, Benjamin P. Willing, Spencer D. Proctor
    Microorganisms.2021; 9(12): 2517.     CrossRef
  • Inverse Association between High-Density Lipoprotein Cholesterol and Adverse Outcomes among Acute Ischemic Stroke Patients with Diabetes Mellitus
    Guoliang Hu, Yuesong Pan, Mengxing Wang, Xia Meng, Yong Jiang, Zixiao Li, Hao Li, Yongjun Wang, Yilong Wang
    Biomedicines.2021; 9(12): 1947.     CrossRef
  • High Incidence of Diabetes in People with Extremely High High-Density Lipoprotein Cholesterol: Results of the Kanagawa Investigation of Total Checkup Data from the National Database-1 (KITCHEN-1)
    Kei Nakajima, Ryoko Higuchi, Taizo Iwane, Michi Shibata, Kento Takada, Michiko Sugiyama, Masafumi Matsuda, Teiji Nakamura
    Journal of Clinical Medicine.2019; 8(3): 381.     CrossRef
  • Total adiponectin in overweight and obese subjects and its response to visceral fat loss
    Salah Gariballa, Juma Alkaabi, Javed Yasin, Awad Al Essa
    BMC Endocrine Disorders.2019;[Epub]     CrossRef
  • Impaired Glucose Metabolism in People with Extremely Elevated High-Density Lipoprotein Cholesterol and Low Alcohol Consumption: Results of the Kanagawa Investigation of Total Checkup Data from the National Database-3 (KITCHEN-3)
    Kei Nakajima, Ryoko Higuchi
    Journal of Clinical Medicine.2019; 8(11): 1825.     CrossRef
  • Phenotyping of Korean patients with better-than-expected efficacy of moderate-intensity statins using tensor factorization
    Jingyun Choi, Yejin Kim, Hun-Sung Kim, In Young Choi, Hwanjo Yu, Katriina Aalto-Setala
    PLOS ONE.2018; 13(6): e0197518.     CrossRef
  • Serum Levels of Apolipoproteins and Incident Type 2 Diabetes: A Prospective Cohort Study
    Adela Brahimaj, Symen Ligthart, M. Arfan Ikram, Albert Hofman, Oscar H. Franco, Eric J.G. Sijbrands, Maryam Kavousi, Abbas Dehghan
    Diabetes Care.2017; 40(3): 346.     CrossRef
  • Psoriasis and metabolic syndrome in children: current data
    A. Pietrzak, E. Grywalska, M. Walankiewicz, T. Lotti, J. Roliński, W. Myśliński, P. Chabros, D. Piekarska-Myślińska, K. Reich
    Clinical and Experimental Dermatology.2017; 42(2): 131.     CrossRef
  • A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex
    Cecilia Frej, Armando J. Mendez, Mario Ruiz, Melanie Castillo, Thomas A. Hughes, Björn Dahlbäck, Ronald B. Goldberg
    Arteriosclerosis, Thrombosis, and Vascular Biology.2017; 37(6): 1194.     CrossRef
  • Improvement in Biochemical Parameters in Patients with Type 2 Diabetes After Twenty-Four Sessions of Aerobic Exercise: A Randomized Controlled Trial
    Soulmaz Rahbar, Sedigheh Sadat Naimi, Asghar Reza Soltani, Abbas Rahimi, Alireza Akbarzadeh Baghban, Vahid Rashedi, Hossein Moein Tavakkoli
    Iranian Red Crescent Medical Journal.2017;[Epub]     CrossRef
  • The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes
    Sangeeta Kashyap, Karim Kheniser, Ling Li, James Bena, Takhar Kasumov
    Lipids in Health and Disease.2016;[Epub]     CrossRef
  • Advances in high-density lipoprotein physiology: surprises, overturns, and promises
    Caterina Constantinou, Eleni A. Karavia, Eva Xepapadaki, Peristera-Ioanna Petropoulou, Eugenia Papakosta, Marilena Karavyraki, Evangelia Zvintzou, Vassilis Theodoropoulos, Serafoula Filou, Aikaterini Hatziri, Christina Kalogeropoulou, George Panayiotakopo
    American Journal of Physiology-Endocrinology and Metabolism.2016; 310(1): E1.     CrossRef
  • Comparative analysis of the efficacy of omega-3 fatty acids for hypertriglyceridaemia management in Korea
    H.-S. Kim, H. Kim, Y. J. Jeong, S. J. Yang, S. J. Baik, H. Lee, S.-H. Lee, J. H. Cho, I.-Y. Choi, H. W. Yim, K.-H. Yoon
    Journal of Clinical Pharmacy and Therapeutics.2016; 41(5): 508.     CrossRef
  • Analysis and comparison of statin prescription patterns and outcomes according to clinical department
    H.-S. Kim, H. Kim, H. Lee, B. Park, S. Park, S.-H. Lee, J. H. Cho, H. Song, J. H. Kim, K.-H. Yoon, I. Y. Choi
    Journal of Clinical Pharmacy and Therapeutics.2016; 41(1): 70.     CrossRef
  • Statin‐related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea
    H.‐S. Kim, S. H. Lee, H. Kim, S.‐H. Lee, J. H. Cho, H. Lee, H. W. Yim, S.‐H. Kim, I.‐Y. Choi, K.‐H. Yoon, J. H. Kim
    Journal of Clinical Pharmacy and Therapeutics.2016; 41(3): 266.     CrossRef
  • Diabetes Associated to Atherosclerosis Risk Factors in Patients of Family Health Unity
    Polyane Medeiros Alves, Raiane dos Santos Pereira, Ariel Gustavo Letti, Álvaro Luís Müller da Fonseca
    Open Journal of Preventive Medicine.2015; 05(04): 177.     CrossRef
  • Cis-9, trans-11 and trans-10, cis-12 CLA Mixture does not Change Body Composition, Induces Insulin Resistance and Increases Serum HDL Cholesterol Level in Rats
    Mariana Macedo de Almeida, Yamara Oliveira de Souza, Sheila Cristina Potente Dutra Luquetti, Céphora Maria Sabarense, José Otávio do Amaral Corrêa, Ellen Paula Santos da Conceição, Patrícia Cristina Lisboa, Egberto Gaspar de Moura, Sara Malaguti Andrade S
    Journal of Oleo Science.2015; 64(5): 539.     CrossRef
  • Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
    Won-Young Lee
    Endocrinology and Metabolism.2014; 29(3): 251.     CrossRef
  • Not All Smokers Die Young: A Model for Hidden Heterogeneity within the Human Population
    Morgan Levine, Eileen Crimmins, Hong Wei Chu
    PLoS ONE.2014; 9(2): e87403.     CrossRef
  • Oxidative Damage and Inflammation in Obese Diabetic Emirati Subjects
    Salah Gariballa, Melita Kosanovic, Javed Yasin, Awad Essa
    Nutrients.2014; 6(11): 4872.     CrossRef
  • Low HDL cholesterol is correlated to the acute ischemic stroke with diabetes mellitus
    Yun Luo, Jingwei Li, Junfeng Zhang, Yun Xu
    Lipids in Health and Disease.2014;[Epub]     CrossRef
  • Butter naturally enriched in cis-9, trans-11 CLA prevents hyperinsulinemia and increases both serum HDL cholesterol and triacylglycerol levels in rats
    Mariana Macedo de Almeida, Sheila Cristina Potente Dutra Luquetti, Céphora Maria Sabarense, José Otávio do Amaral Corrêa, Larissa Gomes dos Reis, Ellen Paula Santos da Conceição, Patrícia Cristina Lisboa, Egberto Gaspar de Moura, Jacy Gameiro, Marco Antôn
    Lipids in Health and Disease.2014;[Epub]     CrossRef
  • Conference report
    Andrew J. Krentz
    Cardiovascular Endocrinology.2014; 3(Supplement): S5.     CrossRef
Close layer
Original Articles
The Association between Low Serum Bilirubin and Carotid Atherosclerosis in Subjects with Type 2 Diabetes.
Byoung Hyun Park, Hye Jung Nho, Chung Gu Cho
Endocrinol Metab. 2012;27(2):126-131.   Published online June 20, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.2.126
  • 15,516 View
  • 25 Download
  • 3 Crossref
AbstractAbstract PDF
BACKGROUND
Bilirubin prevents oxidative modification of low density lipoprotein, and may protect vessels from atherosclerosis. Several studies showed an inverse relationship between serum bilirubin and coronary artery disease. However, there are some needs to clarify the relationship between serum bilirubin and carotid atherosclerosis in type 2 diabetes, especially. METHODS: A total of 346 type 2 diabetic patients, between 35 and 95 years of age (146 men and 200 women), were studied. Subjects with normal serum total bilirubin were divided into two groups, according to their serum total bilirubin levels (group I, total bilirubin > or = 1.0 mg/dL [n = 59]; group II, total bilirubin < or = 0.5 mg/dL [n = 76]). Carotid intima-media thickness (IMT) and plaque scores were measured by ultrasonography. Carotid atherosclerosis was defined by the presence of plaque or more than 1 mm of common carotid IMT. RESULTS: Carotid IMT was positively correlated with age, duration of diabetes and hypertension, high sensitive C-reactive protein (hs-CRP) and fibrinogen, but, it was negatively correlated with bilirubin, gamma glutaryltransferase, albumin, hemoglobin, cystatin C and estimated-glomerular filtration rate (GFR) in all subjects. After controlling for sex, age and levels of hemoglobin, direct bilirubin only was negatively correlated with carotid IMT (r = -0.151, P = 0.034). Low serum total bilirubin group had a lot of female, long duration of diabetes and hypertension, higher hs-CRP, platelet counts, serum creatinine, HbA1c and homeostasis model assessment-insulin resistance, lower albumin, hemoglobin, estimated-GFR and quantitative insulin sensitivity check index. Carotid IMT and plaque scores were significantly greater in low serum bilirubin group (0.785 +/- 0.210 mm vs. 0.678 +/- 0.146 mm, P < 0.01; 1.95 +/- 2.56 vs. 1.03 +/- 1.40, P < 0.05, respectively) than in the high serum bilirubin group. Multivariate logistic regression analysis showed that age, serum albumin and total bilirubin were independent associated factors for carotid atherosclerosis in type 2 diabetic women. CONCLUSION: Total bilirubin is inversely correlated with carotid atherosclerosis in type 2 diabetic patients, and it is an independent associated factor for carotid atherosclerosis in women.

Citations

Citations to this article as recorded by  
  • Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations
    Ai-Ching Boon, Andrew C. Bulmer, Jeff S. Coombes, Robert G. Fassett
    American Journal of Physiology-Renal Physiology.2014; 307(2): F123.     CrossRef
  • Mildly Elevated Serum Bilirubin Levels Are Negatively Associated with Carotid Atherosclerosis among Elderly Persons
    Ryuichi Kawamoto, Daisuke Ninomiya, Yoichi Hasegawa, Yoshihisa Kasai, Tomo Kusunoki, Nobuyuki Ohtsuka, Teru Kumagi, Masanori Abe, Jozef Dulak
    PLoS ONE.2014; 9(12): e114281.     CrossRef
  • Association between Total Bilirubin and Hemoglobin A1c in Korean Type 2 Diabetic Patients
    Seong-Woo Choi, Young-Hoon Lee, Sun-Seog Kweon, Hye-rim Song, Hye-Ran Ahn, Jung-Ae Rhee, Jin-Su Choi, Min-Ho Shin
    Journal of Korean Medical Science.2012; 27(10): 1196.     CrossRef
Close layer
Association of Coronary Artery Disease and Osteoporotic Vertebral Fracture in Korean Men and Women.
Sun Ok Song, Kyung Won Park, Seung Hoon Yoo, Won Jun Koh, Byung Soo Kang, Tae Ho Kim, Hyeong Jin Kim, Yun Hyeong Cho, Deok Kyu Cho, Se Hwa Kim
Endocrinol Metab. 2012;27(1):39-44.   Published online March 1, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.1.39
  • 4,076 View
  • 23 Download
  • 6 Crossref
AbstractAbstract PDF
BACKGROUND
The association of osteoporotic vertebral fracture or osteoporosis with coronary artery disease (CAD) was investigated in Korean men and women. METHODS: Four hundred consecutive postmenopausal women and men aged 50 years and older, undergoing coronary angiography, were enrolled for the evaluation of established or suspected coronary artery disease. CAD was diagnosed if there was narrowing of > 50% diameter in one or more major coronary artery. Morphometric vertebral fracture was assessed using lateral thoracic and lumbar spine radiographs. Bone mineral density was performed using dual-energy x-ray absorptiometry. RESULTS: Of the 400 subjects in the study (mean age of 61.9 +/- 11.6 years), 256 patients had CAD. Vertebral fracture was observed in 94 (23.5%) patients. There was no difference in vertebral fracture according to the presence or absence of CAD. In logistic regression analysis, vertebral fracture was not significantly associated with CAD after adjustment for multiple risk factors. Although women had lower BMD at any given site than men, BMD was not associated with the presence or absence of CAD among 191 patients. CONCLUSION: Our study demonstrated that osteoporotic vertebral fracture or osteoporosis was not associated with coronary artery disease in Korean men and women.

Citations

Citations to this article as recorded by  
  • Associations of subclinical manifestations of coronary and carotid artery atherosclerosis with bone strength parameters in asymptomatic women
    Irina A. Skripnikova, Maria A. Kolchina, Olga V. Kosmatova, Olesia Yu. Isaykina, Vladimir A. Vygodin, Oxana M. Drapkina
    Archives of Osteoporosis.2025;[Epub]     CrossRef
  • Fundamental and practical aspects of coronary artery calcification
    O. L. Barbarash, V. V. Kashtalap, I. A. Shibanova, A. N. Kokov
    Russian Journal of Cardiology.2020; 25: 4005.     CrossRef
  • Assessment of Subclinical Manifestations of Atherosclerosis of Coronary and Peripheral Arteries and Bone Strength Parameters in Women
    I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, M. A. Myagkova, V. E. Novikov, O. Yu. Isaykina, O. M. Drapkina
    Rational Pharmacotherapy in Cardiology.2020; 16(6): 868.     CrossRef
  • Association factor analysis between osteoporosis with cerebral artery disease
    Eun-Sun Jin, Je Hoon Jeong, Bora Lee, Soo Bin Im
    Medicine.2017; 96(9): e6164.     CrossRef
  • VASCULAR CALCIFICATION, ATHEROSCLEROSIS AND BONE LOSS (OSTEOPOROSIS): NEW PATHOPHYSIOLOGICAL MECHANISMS AND FUTURE PERSPECTIVES FOR PHARMACOLOGICAL THERAPY
    A. Dolzhenko, T. Richter, S. Sagalovsky
    Almanac of Clinical Medicine.2016; 44(4): 513.     CrossRef
  • Aortic Calcification and Bone Metabolism: The Relationship between Aortic Calcification, BMD, Vertebral Fracture, 25-Hydroxyvitamin D, and Osteocalcin
    Kwang Joon Kim, Kyoung Min Kim, Kyeong Hye Park, Han Seok Choi, Yumie Rhee, Yong Ho Lee, Bong Soo Cha, Myong Jin Kim, Sun Min Oh, J. Keenan Brown, Sung Kil Lim
    Calcified Tissue International.2012; 91(6): 370.     CrossRef
Close layer
Impact of Serum Adiponectin Concentration on Progression of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus.
Chul Sik Kim, Ju Ri Park, Sung Hoon Yu, Jun Goo Kang, Ohk Hyun Ryu, Seong Jin Lee, Eun Gyung Hong, Doo Man Kim, Jae Myung Yoo, Sung Hee Ihm, Moon Gi Choi, Hyung Joon Yoo
Endocrinol Metab. 2012;27(1):31-38.   Published online March 1, 2012
DOI: https://doi.org/10.3803/EnM.2012.27.1.31
  • 3,420 View
  • 29 Download
AbstractAbstract PDF
BACKGROUND
Increased cardiovascular events, which is the leading cause of death in type 2 diabetic patients, are mainly caused by accelerated atherosclerosis. Adiponectin has been suggested as a risk factor for cardiovascular diseases in cross-sectional studies. However, little is known about the impact of adiponectin on the progression of carotid atherosclerosis in type 2 diabetic patients. This study was conducted to evaluate the impact of early adiponectin levels on the progression of carotid atherosclerosis. METHODS: From March 2009, 150 patients with type 2 diabetes were consecutively enrolled in our affiliated outpatient clinic. Anthropometric and biochemical data, including adiponectin levels, were measured in each participant. We measured the carotid intima-media thickness (CIMT) at baseline and at 1-year follow-up (n = 111). Then, we prospectively studied the relationship between the serum adiponectin levels and the progression of CIMT for 1 year. RESULTS: Adiponectin levels negatively correlated with CIMT (r = -0.219, P = 0.015). Moreover, mean progression of CIMT was 0.016 +/- 0.040 mm. However, there was no correlation between adiponectin levels and the progression of CIMT within 1-year follow-up period (r = -0.156, P = 0.080). Age (beta = 0.556, P = 0.004), LDL cholesterol (beta = 0.276, P = 0.042), and A1C (beta = 0.309, P = 0.038) were found to be independent risk factors for CIMT. However, A1C (beta = 0.311, P = 0.042) was found to be the only independent risk factor for the progression of CIMT. CONCLUSION: In our study, adiponectin levels were negatively associated with CIMT. However, it did not affect the progression of CIMT at 1-year follow-up. Overall glycemic control is the most important factor in the progression of CIMT in patients with type 2 diabetes.
Close layer
Determinants of the Brachial-Ankle Pulse Wave Velocity (baPWV) in Patients with Type 2 Diabetes Mellitus.
Seong Woo Lee, Kyung Won Yun, Yun Sik Yu, Hong Kyu Lim, Yung Pil Bae, Byung Do Lee, Bo Hyun Kim, Chang Won Lee
J Korean Endocr Soc. 2008;23(4):253-259.   Published online August 1, 2008
DOI: https://doi.org/10.3803/jkes.2008.23.4.253
  • 4,097 View
  • 27 Download
  • 5 Crossref
AbstractAbstract PDF
BACKGROUND
Pulse wave velocity (PWV) correlates with arterial distensibility and stiffness and is a useful method for evaluating the severity of systemic atherosclerosis in adults. Brachial-ankle PWV (baPWV) is affected by many different factors such as age, systolic blood pressure (SBP), sex, body mass index, waist to hip ratio, and HbA1c. We evaluated the determinants of baPWV in patients with type 2 diabetes mellitus. METHODS: The study included 803 type 2 diabetic patients over age 30 who had their ankle brachial pressure index (ABI) and baPWV measured at Busan St. Mary's Medical Center, Busan, Korea. Anthropometric parameters, blood pressure, pulse pressure, fasting plasma glucose, fasting insulin, HbA1c, lipid profile, high sensitivity C-reactive protein (hs-CRP), and microalbuminuria were checked concurrently. We also investigated tobacco and alcohol use by means of questionnaire. We then retrospectively analyzed the relationships between baPWV and various risk factors. RESULTS: Differences between men and women were measured using the independence sample probate. Pearson correlation analysis confirmed the factors affecting the baPWV as follows: SBP, diastolic blood pressure, pulse pressure, age, waist circumference, gender, and duration of diabetes mellitus were positively correlated, and height and weight were negatively correlated. On aged-adjusted partial correlation, HbA1c, SBP, diastolic blood pressure, and pulse pressure were correlated. By multiple linear regression analysis, SBP, age, HbA1c, and weight were independent predictors of baPWV. CONCLUSION: The baPWV is principally affected by SBP and age in patients with type 2 diabetes mellitus.

Citations

Citations to this article as recorded by  
  • Factors Affecting Arterial Stiffness and Brachial-Ankle Pulse Wave Velocity in Patients With Type 2 Diabetes
    Tomoki Furuya, Shinji Kitahama, Yuma Tamura, Susumu Ogawa, Yuki Nakatani, Takanori Yasu
    Cureus.2024;[Epub]     CrossRef
  • High Brachial Ankle Pulse Wave Velocity as a Marker for Predicting Coronary Artery Stenosis in Patients with Type 2 Diabetes
    Bo Hyun Kim, Jae Sik Jang, Yong Seop Kwon, June Hyung Kim, In Joo Kim, Chang Won Lee
    Endocrinology and Metabolism.2018; 33(1): 88.     CrossRef
  • Relationships between Brachial-Ankle Pulse Wave Velocity and Peripheral Neuropathy in Type 2 Diabetes
    Byung Kil Ha, Bong Gun Kim, Dong Hyun Kim, Soon Il Lee, Soon Myung Jung, Ja Young Park, Chang Won Lee, Sang Soo Kim, Bo Hyun Kim, In Ju Kim
    Diabetes & Metabolism Journal.2012; 36(6): 443.     CrossRef
  • Relationships between Cardiac Autonomic Neuropathy and the Brachial-ankle Pulse Wave Velocity in Patients with Type 2 Diabetes
    Young Pil Bae, Byeong Do Yi, Bong-Gun Kim, Jong-Hwa Park, Yong Seop Kwon, Ja Young Park, Chang Won Lee, Bo Hyun Kim, Jae-Sik Jang
    Endocrinology and Metabolism.2011; 26(1): 44.     CrossRef
  • Type 2 Diabetes Mellitus and Arterial Stiffness
    Sung Hee Choi
    Journal of Korean Endocrine Society.2008; 23(4): 234.     CrossRef
Close layer
The Relationship between Lumbar Spine Bone Mineral Density and Cardiovascular Risk Factors in Korean Female Adults.
Young Yul Koh, Eun Jung Rhee, Se Yeon Kim, Chan Hi Jung, Cheol Young Park, Won Young Lee, Ki Won Oh, Sung Woo Park, Sun Woo Kim
J Korean Endocr Soc. 2006;21(6):497-505.   Published online December 1, 2006
DOI: https://doi.org/10.3803/jkes.2006.21.6.497
  • 3,705 View
  • 19 Download
  • 4 Crossref
AbstractAbstract PDF
BACKGROUND
Recent studies suggest a possible pathogenic linkage between the osteoporosis and atherosclerosis. We investigated the relationship between cardiovascular risk factors, including high sensitivity C-reactive protein (hs-CRP), insulin resistance, lipid profiles and bone metabolism in Korean females. METHODS: Anthropometric measurements were performed on 437 women (mean age 52 yrs), and cardiovascular risk factors, including fasting blood glucose, fasting blood insulin, lipid profiles and hs-CRP, measured. An atherogenic index was calculated using the serum total cholesterol level divided by the high-density lipoprotein cholesterol (HDL-C) level. The lumbar spine bone mineral density (BMD) was measured using dual X-ray absorptiometry. RESULTS: From bivariate analyses, the lumbar spine BMD showed negative correlations with age, systolic and diastolic blood pressures, serum total cholesterol, low-density lipoprotein cholesterol (LDL-C), triglyceride levels and atherogenic index, and a positive correlation with the HDL-C level. After adjustment for age and BMI, the atherogenic index and HDL-C showed consistent correlation with the lumbar spine BMD. The log-transformed hs-CRP showed no correlation with the lumbar spine BMD. In premenopausal women, age, BMI and atherogenic index showed significant associations with the lumbar spine BMD and the atherogenic index showed consistently significant correlation, even after adjustment for age and BMI. In postmenopausal women, only age and BMI showed significant correlations with the lumbar spine BMD. From multiple linear regression analyses of all the study subjects, age, BMI, atherogenic index and the presence of menopause were found to be determinants of the lumbar spine BMD (R2 = 0.422, p < 0.05), which was consistently significant in analysis performed on premenopausal women (R2 = 0.157, P < 0.05). In postmenopausal women, age and BMI were found to be the determinants of the lumbar spine BMD (R2 = 0.257, P < 0.05). CONCLUSIONS: The lumbar spine BMD was negatively correlated with the atherogenic index in all and in premenopausal women. The menopause seems to play an important role in the relationship of cardiovascular risk factors with BMD in Korean females.

Citations

Citations to this article as recorded by  
  • Comparison of Relationship between Biochemical Indices and Bone Mineral Densityof Pre- and Post- Menopausal Women in Gyeongnam Area
    Mi-Young Park, Sung-Hee Kim
    Journal of the East Asian Society of Dietary Life.2017; 27(4): 408.     CrossRef
  • Relationship between Plasma Lipids and Osteoporosis in Korean Postmenopausal Women
    Kyung Shik Lee, Jae Hwan Cho, Chang Hae Park, Bo Seung Kim, Kyung Hwan Cho, Seung Hwan Lee, Byung Jun Ko, Do Hoon Kim
    Journal of the Korean Geriatrics Society.2011; 15(2): 99.     CrossRef
  • Relationships among Obesity, Bone Mineral Density, and Cardiovascular Risks in Post-menopausal Women
    Heeyoung So, Sukhee Ahn, Rhayun Song, Hyunli Kim
    Korean Journal of Women Health Nursing.2010; 16(3): 224.     CrossRef
  • Association of the Metabolic Syndrome and Bone Mineral Density in Postmenopausal Women
    Jong-Chang Park, Hyuk-Jung Kweon, Yun-Kyo Oh, Hyun-Jin Do, Seung-Won Oh, Youl-Lee Lym, Jae-Kyung Choi, Hee-Kyung Joh, Dong-Yung Cho
    Korean Journal of Family Medicine.2010; 31(1): 9.     CrossRef
Close layer
Comparison of Common Carotid Artery Intima-Media Thickness between Subclinical Hypothyroidism and Euthyroidism.
Kyung Sun Park, Jung Im Rue, Soo Kyung Kim, In Jae Kim, Sang Wook Lim, Seok Won Park, Yu Lee Kim, Dong Hoon Cha, Yong Wook Cho, Young Kil Choi, Sang Jong Lee
J Korean Endocr Soc. 2006;21(6):490-496.   Published online December 1, 2006
DOI: https://doi.org/10.3803/jkes.2006.21.6.490
  • 3,866 View
  • 22 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Common carotid artery intima-media thickness (IMT), which is increased in patients with overt hypothyroidism, is an independent risk factor of the atherosclerosis-related disease. This study was performed to compare serum lipid level and common carotid artery IMT among patients with overt hypothyroidism, subclinical hypothyroidism and euthyroidism. METHODS: Patients with newly-diagnosed subclinical (n=32) and overt (n=32) hypothyroidism were selected for this study. All of the patients and an age- and sex-matched euthyroidism cohort were checked for clinical characteristics and serum lipid levels. Common carotid artery IMT was also measured using high resolution B-mode ultrasonography. RESULTS: Statistically significant differences were observed between the total cholesterol levels of patients with subclinical hypothyroidism and those with euthyroidism. When common carotid artery IMT measured by ultrasonography, subclinical (0.67 +/- 0.11 mm) and overt (0.71 +/- 0.12 mm)) hypothyroidism showed significantly increased mean IMT compared to that of euthyroidism (0.58 +/- 0.07 mm, P < 0.05, respectively), but no differences were found between subclinical and overt hypothyroidism. CONCLUSION: We concluded that subclinical hypothyroidism is related to increased common carotid artery IMT as well as dyslipidemia. Therefore, we recommend that treatment principle of subclinical hypothyroidism be established through large-scale, prospective studies performed to determine the effect of thyroid hormone replacement on the reduction of common carotid artery IMT.

Citations

Citations to this article as recorded by  
  • The Effect of Brief Thyroid Functional Changes on Arterial Stiffness in Patients Who Preparing Radioactive Iodine Administration
    Ho-Su Kim, Jae-Hoon Jung, Jung Hwa Jung, Soo Kyoung Kim, Sungsu Kim, Jeong Rang Park, Rock Bum Kim, Jong Ryeal Hahm
    International Journal of Thyroidology.2015; 8(2): 161.     CrossRef
  • Changes of Body Composition, Blood Concentrations of Lipid Profiles and Thyroid Hormone After Exercise Training in Hypothyroid-induced Rat
    Kijin Kim
    The Korean Journal of Obesity.2012; 21(1): 65.     CrossRef
Close layer
The Effect of Hormone Replacement Therapy on Carotid Intima-Media Thickness in Healthy Postmenopausal Women.
Jang Yel Shin, Bong Soo Cha, Choon Hee Chung, Won Heum Shim, Hyun Chul Lee
J Korean Endocr Soc. 2006;21(1):14-21.   Published online February 1, 2006
DOI: https://doi.org/10.3803/jkes.2006.21.1.14
  • 3,048 View
  • 24 Download
AbstractAbstract PDF
BACKGROUND
Cardiovascular disease is the leading cause of death in postmenopausal women. The use of hormone replacement therapy (HRT) preventing for cardiovascular disease in postmenopausal women remains controversial. We investigated the effect of HRT on carotid intima-media thickness (IMT) according to the HRT duration in healthy postmenopausal women. METHODS: One hundred and twenty postmenopausal women (mean age: 55.4 +/- 3.3 years) were classified into never users, short-term, and long-term users according to the HRT duration. Carotid IMT was measured, and the clinical and biochemical cardiovascular risk factors were examined. RESULTS: The mean IMT was significantly thinner in the long-term users than that in the never users (0.62 +/- 0.11 vs. 0.71 +/- 0.14 mm, P < 0.01). Also, the maximal IMT was significantly thinner in the short-term and the long-term users. However, there is no significant difference in the mean and maximal IMTs between the estrogen alone and estrogen plus progestins used group. The period exposed to menopause was significantly shorter in the long-term users than that in the never users (1.8 +/- 2.3 vs. 4.3 +/- 3.3 years, P < 0.001). CONCLUSION: Our findings suggest that if HRT is initiated during early postmenopausal period before the onset of atherosclerosis, HRT may have a beneficial effect on the prevention of carotid atherosclerosis.
Close layer
Role of Thigh Muscle in the Carotid artery Intima-Media Thickness and Insulin resistance.
ll Jun Hwang, Kyung Sun Park, Yun Tae Chae, Kyeh Dong Shi, Soo Kyung Kim, Seok Won Park, Yu Lee Kim, Yong Wook Cho, Young Kil Choi, Sang Jong Lee
J Korean Endocr Soc. 2005;20(5):452-459.   Published online October 1, 2005
DOI: https://doi.org/10.3803/jkes.2005.20.5.452
  • 3,102 View
  • 18 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
There have been recent reports that the fat distribution within skeletal muscle and the amount of muscle mass are associated with insulin resistance and the development of type 2 diabetes mellitus (T2DM). This study evaluated the impacts of visceral fat and thigh muscle from patients with T2DM and healthy subjects on atherosclerosis and insulin resistance. METHODS: Forty-two patients with newly-developed T2DM and 11 healthy subjects were selected for the study. The diabetic patients were subdivided into two groups, those under 40 years of age, as the young T2DM (n=21) group, and 40 years-old or greater, as the old T2DM (n=21) group. CT scans were obtained for all patients at the L4-L5 level and at the mid-portion between the greater trochanter and upper margin patella. The carotid intima-media thickness (IMT) was also measured using high resolution B-mode ultrasonography. RESULTS: The mean visceral fat area (VFA) in the old T2DM group was 169.4+/-13.2cm2, which was significantly greater than that found in the healthy subjects (67.9+/-7.92cm2, P<0.001) and young T2DM group (127.1+/-10.4cm2, P<0.05). The mean visceral fat to normal density muscle area ratio (VMNR) in the old T2DM group was 1.50+/-0.19, which was greater than in the healthy subjects (0.46+/-0.52, P<0.001) and young T2DM group (1.01+/-0.10, P<0.05). The total thigh muscle areas in the young and old T2DM groups were smaller than that in the healthy subjects, but without statistical significance. VMNR showed a positive correlation with the IMT and HOMA-IR. However, the total thigh muscle area was negatively correlated with the IMT. The normal density muscle area also showed significant negative correlations with the IMT and HOMA-IR. In a multiple regression analysis, age and VMNR were the most important independent risk factors of an increased carotid IMT. CONCLUSION: This study showed that the role of thigh muscle, as well as that of visceral fat, played a very important role in the occurrence of atherosclerosis. VMNR was found to be an especially important independent factor for an increased carotid IMT.

Citations

Citations to this article as recorded by  
  • High fat stores in ectopic compartments in men with newly diagnosed type 2 diabetes: an anthropometric determinant of carotid atherosclerosis and insulin resistance
    S-K Kim, S-W Park, I-J Hwang, Y-K Lee, Y-W Cho
    International Journal of Obesity.2010; 34(1): 105.     CrossRef
Close layer
Relationship between Plasma Leptin Levels and Carotid Intima-Medial Thickness in Korean Adults.
Hyejin Lee, Eunsoon Hong, Youngsun Hong, Yeon Ah Sung
J Korean Endocr Soc. 2002;17(1):87-94.   Published online February 1, 2002
  • 1,804 View
  • 18 Download
AbstractAbstract PDF
BACKGROUND
Many studies have recently shown that leptin can promote angiogenesis via endothelial leptin receptors and induce oxidative stress in endothelial cells; These findings suggest the relationship between cardiovascular risk and blood leptin concentration. In the present study, we investigated the relationship between leptin concentration and carotid intima-medial thickness (CIMT) as an indicator of early atherosclerosis in adults. METHEODS: The study subjects comprised 138 (45 men and 93 women; mean age 42.4+/-7.5 years; mean BMI 24.0+/-2.7 kg/m2) without history of diabetes, hypertension or cardiovascular disease. We measured CIMT by high resolution ultrasonography and plasma leptin levels by radioimmunoassay. RESULTS: 1) No significant differences in age, BMI or CIMT between male and female subjects were noted, but the leptin levels in female were significantly higher than those in males. (8.42+/-5.90 ng/mL vs. 3.08+/-1.00 ng/mL, p<0.001) 2) CIMT showed a significant positive correlation with age (r=0.31, p< 0.001), BMI (r=0.25, p<0.01) and level (r=0.42, p<0.05) in simple regression analysis. 3) When male and female subjects were each divided into 3 groups by leptin concentration, no significant difference in CIMT among female subjects was found. In male subjects, CIMT was significantly higher in the highest tertile of leptin level than in the other 2 groups (0.65+/-0.03 mm vs. 0.56+/-0.07 mm and 0.53+/-0.07 mm, p<0.01) after adjustment for BMI and age. However, this difference was not significant after adjustment for smoking. 4) CIMT (0.61+/-0.05 mm vs. 0.53+/-0.07 mm, p<0.01) and leptin concentrations (3.57+/-2.13 ng/mL vs. 2.20+/-1.39 ng/mL, p<0.05) were significantly higher in male smokers than in male non-smokers. CONCLUSION: Our results demonstrated significant correlation of CIMT to plasma leptin level before adjustment for smoking. A possible explanation is the permissive action of smoking on the atherogenic effect of leptin. However, further studies to elucidate the relationships and interactions among smoking, leptin level and the development of atherosclerosis will be needed.
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP